uicc annual report 2003

UICCAnnual Review

International Union Against Cancer (UICC)Union Internationale Contre le Cancer

UICC Council 2003Executive Commitee President:John R. Seffrin (U.S.A.) Chair of the Finance Committee: John C. Baity (U.S.A.) Past President: Eliezer Robinson (Israel) Treasurer: Louis J. Denis (Belgium) Members elected by the Council: Mary Gospodarowicz (Canada) Arun P. Kurkure (India)

Strategic LeadersRobert Burton (Australia) Kenneth Nilsson (Sweden) Yussuf Saloojee (South Africa) Hélène Sancho-Garnier (France)

MembersGraeme Brien Australia) Michael Daube (Australia) Ketayun A. Dinshaw (India)Liisa Elovainio (Finland)

Tom Hudson (Ireland) Tomoyuki Kitagawa (Japan) Ray Lenhard (USA) Antonio Llombart-Bosch (Spain)Melissa S. Luwia (Indonesia) Claire Mallinson (UK) Ivano Humbert Marchesi (Brazil) H. Fred Mickelson (USA) Sherif Omar (Egypt)Thierry Philip (France) Odd Søreide (Norway) Robert Schweitzer (USA) Kazuo Tajima (Japan) Walter Weber (Switzerland) Susie Wilkinson (UK) David M. Zacks (USA) David Zaridze (Russia) You Hui Zhang (China) Miri Ziv (Israel)

Editor, International Journal ofCancerHarald zur Hausen (Germany)Executive DirectorIsabel Mortara (Switzerland)

Donors 2003

American Cancer Society, USAASCO, USAAssociation of UICC FellowsAstraZeneca, UKAventis Pharma SABayer, USABristol-Myers Squibb Co., USACanadian Cancer Society, CanadaCancer Council Australia, AustraliaCancer Association of South Africa,South AfricaCancer Research UK, UKCenter for Disease Control, USAConcorde Services Ltd., UKDanish Cancer Society, DenmarkDeutsche Krebshilfe, GermanyDr Mildred, Scheel Foundation,GermanyDutch Cancer Society, NetherlandsEuropean Commission, BelgiumFinnish Cancer Society, FinlandFrench National League AgainstCancer, France

Foundation Open Society Institute,SwitzerlandGlaxo Smith Kline, UKHellenic Cancer Society, GreeceHelvetia Patria, SwitzerlandInternational Union AgainstTuberculosis & Lung Disease,FranceIsrael Cancer Association, IsraelItalian Association for CancerResearch, ItalyJapan National Committee forUICC, JapanJohn Wiley & Sons Inc., USAKyowa Hakko Kogyo Company,JapanLeysin American School, SwitzerlandMundiPharma International Ltd., UKNational Cancer Institute, CanadaNational Cancer Institute, USANordic Cancer Union, IcelandNorwegian Cancer Society, NorwayNovartis, Switzerland

Oncology Nursing Society, USAOffice Fédérale de la SantéPublique, SwitzerlandPharmacia & Upjohn Co., USAPfizer Inc., USAPfizer Foundation Inc., USARoll of Honour, SwitzerlandSwedish Cancer Society, SwedenSwiss Cancer League, SwitzerlandToray Industries, JapanWCTOH Conference, FinlandWilliam Rudder, Memorial Fund,AustraliaWorld Health Organization,Switzerland

Supporting Suppliers2003

Deloitte & Touche, SwitzerlandGyro Group, SwitzerlandSun Microsystems

2 UICC Annual Review 03

3UICC Annual Review 03

Table of contents

UICC Leadership 2003 2Donors 2003 2Joint message from the President and the Executive Director 4 Industry Advisory Council 5Introduction 6Prevention and Early Detection 7Tobacco Control 10Knowledge Transfer 13 Capacity Building 16New Horizons 20Global Activities 22 UICC Roll of Honour 24UICC Task Forces 25UICC Volunteer Committees 27Fellows 2003 28Financials 29UICC Staff 31

VisionUICC’s vision is of a world where cancer is eliminated as a major life-threateningdisease for future generations.

MissionUICC’s mission is to build and lead the global cancer control community engagedin sharing and exchanging cancer control knowledge and competence equitably,transferring scientific findings to clinical settings, systematically reducing andeventually eliminating disparities in prevention, early detection, treatment andcare of cancers, and delivering the best possible care to all cancer patients.


Joint message from the President and the Executive Director The opportunity to save lives and to contribute to well-being has never been greater.

Cancer is potentially the most preventable and the most curable of major life-threatening diseasestoday. However, if current trendscontinue, we will witness a sharprise in the global cancer burdenover the next decades. Despite anunprecedented understanding ofcancer, the gap between what isscientifically known and what ispractically applied is widening on a global scale. Almost every daythe media announces a discoveryor breakthrough. But reports oftenfail to mention the time needed to understand the implications ofnew findings, assess benefits andrisks, translate results into treatmentsand make these accessible to themany, not just the few.

As the only international non-governmental organization withthe singular goal of fighting cancerglobally, UICC engages committedcancer organizations throughoutthe world and together with itsmembers and partners serves as a catalyst for responsible dialogueand collective action, while buildingcommunities of professionals.These include cancer and healthprofessionals, educators, survivors,advocates, cancer society staff and

volunteers - all working towards a concerted goal - to eliminatecancer as a major life-threateningdisease for future generations.

This Annual Review showcases theprincipal themes and actions drivingUICC progress and achievementsduring 2003 under the four strategicdirections defined by UICC memberorganizations and Council. In doingso, it testifies to the evolution ofour role in identifying major issuesand building collaborative solutionsas we tackle the global cancer burden. Activities focus on trainingand education, information sharing,campaigning and network-buildingbetween organizations and individuals in different resourcesettings.

In 2003, the adoption of theWHO Framework Convention onTobacco Control, of which UICCwas a vocal and strong proponent,was a historic victory for the cancer and tobacco control community. The world’s first globalhealth treaty nonetheless representsjust one battle in a long war. The next campaign will involvetranslating the convention intospecific legal provisions while

building and supporting local part-nerships to ensure implementation.Through our broad, cross-sectorpartnerships such as the GlobalAlliance for Cancer Control, we are striving to ensure thatCancer Control is on the agendaof global leadership groups as wellas developmental and governmentalagencies, while providing a forumfor addressing barriers to progress.Worldwide cancer control will onlybe effective if it is given priority at the very highest decision-makinglevels.

Let us not lose sight of the factthat the hopeful side of cancer has never been more hopeful. We take this opportunity to thankUICC members, volunteers, partners, staff and our championswhose relentless efforts inspire usand without whom we could notachieve all that we do. It is onlytogether through a well organizedeffort that we will be able to meet the formidable but not insurmountable challenges ahead.

Dr John SeffrinUICC President

Isabel MortaraUICC Executive Director

Dr John SeffrinUICC President

Isabel MortaraUICC Executive Director


Particular thanks to Industry Advisory Council 2003 members.

The UICC Industry Advisory Council is open to leaders of the medical supply and technology, pharmaceutical, health publishing industries, as well as other leading private sector companies.

* Now Group Sanofi Aventis

Industry Advisory CouncilUICC is grateful to the corporate members who through the Industry AdvisoryCouncil have supported the four strategic directions of Prevention and EarlyDetection, Tobacco Control, Knowledge Transfer and Capacity Building viaunrestricted grants. Many of the activities described in the annual review would not have happened without their support.

Novartis Oncology Bristol-Myers Squibb John Wiley & Sons

Aventis*

Mundipharma Pfizer

PURDUE

Purdue Pharma


Since 2002, all UICC programmesand activities have been developedunder four strategic directions:Prevention and Early Detection;Tobacco Control; KnowledgeTransfer; and Capacity Building.

Within this framework, UICC’swork is focused on a number ofcore activities. The first is creatinginformation resources within ourown organisation, helping mem-bers and other groups create theirown resources, and developingsupports for information storage,analysis, access and dissemination.This Annual Review provides anoverview of the wide range ofinformation resources developedor administered by UICC, includingthe International Journal of Cancer, publications such as TNMClassification, the Manual ofClinical Oncology, newslettersand websites, and the forthcomingpublication Evidence-based CancerPrevention: Strategies for NGOs –A UICC Handbook for Europe.

A second core activity is advocacyand influencing public policy, eitherdirectly, through efforts to help ourcommon initiatives find their wayinto national health strategies orthrough support for other initiatives,or indirectly, through support,training and grants to campaigners,

notably those now seeking nationalimplementation of the FrameworkConvention on Tobacco Control.

A third area of focus is educatingand training cancer control professionals, through diverseFellowship schemes, conferences,and training workshops and materials which can be adapted to be locally relevant.

We also place much emphasis oncommunication and collaborationwith and between UICC membersand other organisations, agenciesand groups working in similarareas, with a view to developingstrategic alliances and leveragingresources for common projects.Partners include health-relatedNGOs like the World HeartFederation, whose aims complementours in the field of cardiovasculardisease prevention, as well as anumber of inter-governmentalorganisations, most notably theWorld Health Organization andthe International Agency forResearch on Cancer (IARC), partners in the Alliance for GlobalCancer Control.

In addition, GLOBALink serves as a unique communications tool fordisseminating information andbuilding dialogue across the globe.

Last but by no means least, wefocus on caring. In practice, thismeans development of networksand support for cancer patientsand their families through volunteerprogrammes like Reach for RecoveryInternational. It also means recognising the financial constraintsthat limit cancer care in manycountries and necessitate thedevelopment of basic practicalcourses for nurses and Fellowshipsfor nurses and educators.

UICC remains at the forefront in raising awareness about modelsand concepts in cancer care forthe benefit of communitiesworldwide, drawinginspiration from projects such as HopeLodges, which respondto the needs of cancerpatients in treatmentfar from home andtheir families, as wellas empowering cancersurvivors and theirfamilies as strongpartners in the globalfight against cancer.

IntroductionAt UICC, our vision is of a world where cancer is eliminated as a major life-threatening disease for future generations. At present, one third of all cancercases are preventable, a further third curable (given early diagnosis and effectivetreatment), while the final third can benefit greatly from palliative care. Ourchallenge is to – gradually and painstakingly – translate these facts into reality.


Prevention and Early Detection The next decade. In the coming years, scientific breakthroughs will lead tonew therapies and preventive interventions. However, it could take decadesbefore new vaccines and drugs will reduce incidence, mortality and sufferingfrom cancer in all countries. Within the next ten years global trends in cancercontrol could be significantly improved through successful primary preventionand early detection strategies.

Effective cancer prevention strategiesBy applying existing evidence-basedknowledge it is possible to preventat least one-third of the estimated10 million cancer cases that occureach year throughout the world and,with early detection, to cure at leastanother 30 percent. Prevention is achieved by eliminating or minimising exposure to the causesof cancer. Early detection can beachieved either by screening or byincreasing early diagnosis. Thiscost-effective long-term approachoffers the greatest public healthpotential.

Evidence-based CancerPrevention: Strategies forNGOs – A UICC Handbookfor EuropeThe challenge of reducing the cancer burden today lies in transferring knowledge aboutappropriate lifestyle choices intobehavioural and societal changes,by increasing the facilities for earlydetection and by ensuring effectivetreatment.

In 2003, a UICC Task Force developed a handbook on cancerprevention strategies specificallyfor the use of European non-governmental organisations, whichis also of great value to health professionals, health authorities,planners, policy makers and educators. The handbook, developed in partnership with theSwiss League Against Cancer andthe French League Against Cancer,will be launched in 2004.

French, Italian and German translations are also being plannedin collaboration with the FrenchLeague Against Cancer, the ItalianLeague Against Cancer with supportfrom donors such as Credit Suisse.Because the pattern of cancer isnot the same everywhere, regionalversions of the handbook will bedeveloped for other parts of theworld, starting with Asia and LatinAmerica in 2005 supported by anAmerican Cancer Society Challengegrant.

Evidence-based CancerPrevention: Strategies for NGOs –A UICC Handbook for Europeincludes information on:• Europe’s cancer burden• The role of social factors• The theoretical aspects of

behavioural change• Successful cancer prevention

activities• The effectiveness of prevention

on major risk factors• The benefits/risks of screening

programmes• Recommendations for

prevention programmes.

Successful early detectionIn developing countries, 80-90percent of cancer patients alreadysuffer from advanced and incurablecancers at the time of diagnosis.There are two principal componentsof early detection programmes – education of the population, andtraining of health care professionals.Both early diagnosis and screeninglead to decreased incidence andmortality, but only if access toeffective treatment is provided.

UICC recognizes that governmentsoperate with limited resources forcompeting health priorities. Thesepriorities are often focused on thetreatment of disease rather thanits prevention. There is an urgentneed to support evidence-basedand cost-effective interventions inthe areas of prevention and earlydetection.

Cervical cancerIn many low-income countries,cervical cancer is the most commoncancer and a leading cause ofdeath among women. Globally,there are more than 470,000 newcases of cervical cancer per year,with almost 80-90 percent ofthem occurring in women who livein low-income countries, many ofwhom are not even diagnosed. A successful screening programmecan greatly reduce the incidenceand mortality from cervical cancer.

Early detection of cervicalcancer in Latin AmericaA series of cytology-based demonstration projects have beencoordinated by UICC in collaborationwith members in El Salvador,Guatemala, Honduras and theDominican Republic. The projects,focusing on rural or urban under-privileged populations, had to overcome many obstacles includingcultural taboos and machismo,poor relationships with localauthorities and language barriers.However, women were informedthrough activities such as door-to-door visits by health workers,neighborhood talks by local leadersand hospital counseling.

It is noteworthy that in 2002 El Salvador’s Health Ministry setup a national cervical cancer control plan.

This five-year project, which cameto an end in 2003, was supportedby the Norwegian Cancer Society.A follow-up meeting, scheduled totake place in Dublin, Ireland, inconjunction with the UICC WorldConference for Cancer Organizations(November 2004), will share the final results of the project and discuss the transition from UICC-sponsorship to a post-UICC environment.

In 2002 and 2003 pilot projects for early detection of cervical cancer were launched in Cambodia,supported by the UICC FrancophoneCommittee and the French LeagueAgainst Cancer. Plans are underwayto extend pilot projects to othercountries, including Cameroon and Tunisia.


These women from San Juan Sacatepéquez (Guatemala) were screened and treated by theGuatemalan League against Cancer within the UICC cervical cancer pilot project.


Country profilesDuring 2003 UICC has supportedthe development of a database oncomprehensive country profiles whichcan be used to prioritise resourceallocation based on needs assessment.This bank of information will makeUICC well-placed to offer moreadequate policy advice on whereand how to invest in cancer control,based on the capacity of countriesto provide essential follow-up services.

Cancer Registration: In 2003 the Honduran Ministry of Healthadopted the cancer registry of theHonduran League Against Cancer(Tegucigalpa) as the referencepopulation-based registry for theentire country. This registry wasdeveloped as a collaborative projectwith UICC, the Norwegian CancerSociety and the Maes HellerCancer Institute as a demonstrationproject.

AbstractPlus: A Spanish version of a CDC hospital-based cancerregistration software has beendeveloped and is currently beingpilot-tested with a view to facilitating the collection, editingand reporting of data in Spanish-speaking countries. This softwarewill soon be available at no chargeon-line. With minimal training,registrars will be able to registerand report data in a uniform wayenabling analysis and comparisonof data and trends in differentregions. This project is the result of a collaborative effort betweenUICC, US Centres for DiseaseControl and Prevention (CDC) and the International Agency forResearch on Cancer (IARC) whichwill ensure full software compatibilitywith CanReg, the population-basedsoftware of IARC.

Training: An online database oftraining opportunities around theworld in epidemiology, cancer registration and strategic analysisis currently being compiled with a view to promoting these opportunities in countries in needand to funding fellowships toenable participation from middleand low income countries.

In 2003, through dedicated grants, UICC assisted registrars,epidemiologists and data managersto attend specialized meetings.One example was the GRELL workshop (Groupe des Registresde Langue Latine) in Cuba in May,2003, where attendees were exposedto registration techniques and concepts in epidemiology andbecame part of a network for further communication.

UICC Tobacco FarmingDiversification Project UICC-backed tobacco prevention project targetsprofitable alternative cropsA pilot project, managed by the Francophone Committeeunder the auspices of UICC, hassucceeded in replacing tobaccowith alternative agricultural products in six test farms, andproving that they can be viable.

The project is being undertaken in partnership with the French andTunisian Leagues Against Cancer,with the former providing fundingand project expertise and the latter agricultural know-how, follow-up activities, and qualityand cost checks after each newsite installation. For its part, theUICC Tobacco Farm ConversionProject team visits sites on a

regular basis to monitor projectstatus and evaluate the longer-termeffects on the local economy andenvironment.

The project’s mid-term goal is toconvert four tobacco-producingfarms in the north-west region of Tunisia to alternative – butequally or more profitable – forms of agriculture. Long-term, thehope is that all 3,640 hectaresunder tobacco cultivation will be converted to other types offarming with a view to eliminatingtobacco production from Tunisia’s agricultural sector.

Pilot projects in Africa

A poster developed from a children’s drawing contest hasbecome a new health educationtool in Africa. Slated for distributionto schools across the continent,the poster was created in 2003 as part of a UICC partnership withthe French League Against Cancer,which is actively developing prevention programmes andhealth education initiatives forfrancophone Africa.

Each year tobacco causes morethan 4.9 million premature deathsworldwide – 1 million in China,800,000 in India, 420,000 in theUSA, 400,000 in Central & EasternEurope, and 120,000 in Sub-SaharanAfrica. If current trends persist, intwo or three decades the globaldeath toll is expected to doubleto 10 million deaths a year.

This expected increase could beforestalled if people would stoptobacco use. A comprehensiveapproach is needed to deter people from taking up the habit,to support existing smokers togive up smoking, to reduce harmfor those who do not quit, and to protect non-smokers from exposure to tobacco smoke.

UICC’s principal tools in the fight against tobacco use areadvocacy, information, trainingand collaborative partnerships. A significant advance occurred inMay 2003 with the adoption bythe 192 members of the WorldHealth Organization (WHO) ofthe historic Framework Conventionon Tobacco Control (FCTC).UICC and its member organisations,in partnership with the FrameworkConvention Alliance, played aninstrumental role in moving thisprocess forward, helping NGO

representatives take part in negotiations within the UICC delegation, and – through ouronline tobacco-control network,GLOBALink – providing a vitalinformation and communicationschannel for activists and tobaccocontrol professionals throughoutthe world.

The FCTC has to date been signedby 168 WHO member states andratified by 31. The treaty willbecome international law after 40countries have ratified it. TheConvention, a first in the field ofpublic health, provides UICC withthe impetus to now take the process a step further, in concertwith its members and partners.

UICC will provide support for the critical phase of national implementation, administering grantsfor the implementation of theFCTC in low-income countries.

The FCTC represents a hugeopportunity for change and forthe development of the kind ofgrass-roots activity that will catalyse change and serve as aneffective national lobby for governments to ratify, accede toand implement the treaty. As partof our ongoing efforts to tacklethe growing global cancer burden,tobacco control should be a toppriority for governmentsand communitiesworldwide. UICC’snew GLOBALinkTobacco ControlPetitions service,launched early2003, whichalready boastsover 13,000 signatures, facilitatesthis process.


Tobacco Control Winning the global battle against tobacco. Throughout the second half of the 20th century it has been clear that cigarette smoking and tobaccouse cause cancer. They increase the risk of cancer of the bladder, cervix, colon, kidney, larynx, lung, oral cavity, oesophagus, pancreas, rectum and stomach.

Yussuf Saloojee, UICC Strategic Leader forTobacco Control, with Emily Bleimund of ACS and an FCTC conference delegatein Geneva.


FCTC measuresMeasures for reducing thedemand for tobacco:• Price and tax measures• Protection from exposure to

environmental tobacco smoke• Regulation and disclosure of

contents of tobacco products• Packaging and labelling (bigger

health warnings, bans on misleading labels like ‘light’ and ‘mild’)

• Education, communication, training and public awareness

• Comprehensive bans and restrictions on tobacco advertising, promotion and sponsorship

• Tobacco dependence and cessation measures

Measures for reducing the supplyof tobacco:• Elimination of the illicit trade of

tobacco products• Restriction of sales to and

by minors• Support for economically viable

alternatives for growers

“This treaty will be as importantin reducing deaths from tobaccouse as the sanitary laws of the19th century were in controllingcholera and infectious disease; however, the greatest challengesnow lie before us. The treatywill only be effective if it isquickly ratified and implementedby the nations of the world.UICC and its 280 memberorganizations are working tirelessly toward that goal.”

Dr Yussuf Saloojee, UICC Strategic Leader for Tobacco Control

A worldwide network,dedicated to changeGLOBALink hailed as vital tool in the battle against tobaccoUICC’s GLOBALink crowned 10 years of solid achievement as the winner of the Luther L. Terry Award for “OutstandingOrganization” at the 2003 WorldConference for Tobacco or Health.Presenting the award, AmericanCancer Society National BoardChairman David Zacks commendedthe network’s “unique ability to mobilise diverse groups of

advocates” which had beeninstrumental, he said, “in rallyingsupport for the passing of theWHO Framework Convention onTobacco Control.”

GLOBALink is an online communityuniting advocates, policy makers,researchers, educators, doctors,economists, and lawyers in theinternational tobacco controlmovement. Since 1993, it has provided a forum for experts andlaypersons alike, who can freelysubscribe to numerous subjectlists, exchange e-mails, and readdaily compilations of news pluscontributions and messages fromother list members.

A benchmark of GLOBALink’s success is the astonishing growthin membership, which has seensustained increases of around 10 percent every six months.

GLOBALink also serves local,regional and other specialisedtobacco control groups. Developedand administered by UICC staff inGeneva, GLOBALink offers a dailynews service and LOCALink web hosting services, exploiting itsextensive global network to helppublicise local tobacco controlseminars and workshops. In additionto English, LOCALink networksalready exist in Arabic, Czech,French, Italian, Portuguese,Romanian, Russian, Spanish, andSwedish, with priority now beinggiven to further expanding thenumber of languages on offer.

In the post-FCTC period GLOBALinkwill also increasingly focus onimplementation. As more andmore states begin to draft andenact tobacco control legislation,GLOBALink will have an importantrole in sharing best practice, toavoid creating loopholes in thelaw, which the industry can exploit to by-pass legislation.

David Zacks (left) and Mary Simmonds (far right) with Isabel Mortara and Ruben Israelbefore the presentation of the Luther L. Terry Award.

Funding tobacco controland training – a collaborative ACS,Cancer Research UK andUICC activityThe resources available to peoplecampaigning for tobacco controlare only a tiny fraction of thosedevoted to tobacco promotion.Faced with a decline in smokingrates in wealthier countries, thetobacco industry is increasinglytargeting the developing world. To counter this, UICC is workingto assign the limited funds availableto areas where the greatest multipliereffects can be achieved.

In 2003, tobacco control advocatesin Africa, Asia, Central and EasternEurope, and South America weregiven a first wave of 13 FCTCimplementation grants, with atotal value of US$115,000. Eachgrant supported the work of keycampaigners in developingeconomies.

UICC and its partners, CancerResearch UK and the AmericanCancer Society (ACS), announcedgrants during the 12th WorldConference on Tobacco or Healthin August 2003. Speaking at thatevent, Dr John R. Seffrin, UICCPresident and ACS CEO, said:“The individuals and organisationswho are the first recipients of theseawards are on the front line ofglobal tobacco control and, if thissupport enables them to promotethe ratification, implementationand enforcement of the FCTC intheir countries, the whole world – all of us – will benefit.”

In addition, a further series of 16one-year Tobacco Control SeedGrants (TCSG) worth US$9,000each were awarded to tobaccocontrol advocates in middle orlower-income countries. Thesegrants, sponsored by ACS, willhelp cover the costs for newtobacco control initiatives thatdevelop community or countrycoalitions and alliances.

Also in 2003 a series of advocacyworkshops were held in collaboration with ACS and aseries of four Tobacco ControlStrategy Planning Guides wereissued. Addressing specific challenges in tobacco controladvocacy, each guide is designedto help advocates overcome barriers to effective tobacco control policies.


The 12th World Conference on Tobacco orHealth: Global Action for a Tobacco FreeFuture, held in Helsinki, Finland from 3-8August 2003, was another high point for thetobacco control community, with countryrepresentatives and a UICC delegation participating. GLOBALink also hosted a cyber café which was a popular feature of the conference.

Also in 2003 GLOBALink released a seriesof online radio interviews on World NoTobacco Day which were picked up by the international media.


The last twelve months have seenthe revision and updating of many classic UICC publications,the organisation of a series ofimportant UICC conferences, seminars and workshops, and anew intake of UICC researchFellows. Through activities such as these, UICC is pursuing the vitalgoal of sharing and transferringknowledge and expertise.

UICC Fellowship programmes: networks of knowledgeA commitment to effectiveinformation exchangeUICC offers a variety of Fellowshipprogrammes ranging from onemonth to one year or more, alongwith specialised short “reverse”

International Cancer TechnologyTransfer Fellowships.

These programmes are part ofUICC’s ongoing commitment toencourage knowledge exchange,increase carer expertise, ensureclinicians are trained in the latesttechnologies, and build capacityamong health professionals,activists and volunteers dedicatedto cancer prevention.

UICC Fellowships are much more than a vehicle for individualprofessional development. Theycreate a multiplier effect, withFellows transmitting the knowledgeand expertise they gain from theirhost organizations to colleagues andinstitutions in their own countries.In the same way, host organisationsbenefit from Fellows’ uniqueknowledge, experience and information on conditions in their own countries.

Current UICC Fellowships Translational Cancer ResearchFellowships (TCRF)Duration: twelve monthsTarget group: experienced scientistsand cliniciansAim: to accelerate clinical or population application of newideas, drugs and treatments, vaccinesand other effective strategies forprevention or intervention.

Sponsors: Aventis (2003),AstraZeneca (2003), NationalCancer Institute (USA), Novartis(Switzerland)

American Cancer SocietyInternational Fellowships forBeginning Investigators(ACSBI)Duration: twelve monthsTarget group: investigators andclinicians in the early stages oftheir careerAim: to assist academic careerdevelopment in various aspects of cancer research (applied, clinicaland pre-clinical, basic, health policy, patient care, etc).Sponsor: American Cancer Society

Knowledge TransferBridging the gap. As the huge global disparity between scientific knowledgeand practical application increases, so the gap is also widening between different communities’ access to cancer information, prevention and screeningworldwide. Through its efforts in the field of Knowledge Transfer, UICC is actively seeking to reverse these trends.


Yamagawa-Yoshida MemorialInternational Cancer StudyGrants (YY)Duration: three monthsTarget group: qualified and experienced cancer investigatorsAim: to set up or carry out bilateral research projects usingcomplementary skills and materials.Sponsors: Japan National Committeefor UICC, Kyowa Hakko KogyoCo. Ltd., Toray Industries Inc.

International Cancer ResearchTechnology TransferFellowships (ICRETT)Duration: one monthTarget group: qualified cancer professionals, generally in the earlystages of their careersAim: rapid acquisition of specificskills in cancer research or treatment,diagnosis and prevention.

“Reverse” ICRETTDuration: one week to one monthTarget group: groups of up to 30 qualified professionals in cancerinstitutes, clinics or hospitals in low or middle-income countriesAim: to conduct teaching andtraining courses.ICRETT and “Reverse” Sponsors:Association of UICC Fellows,American Society of ClinicalOncology (ASCO), The CancerCouncil Australia, Cancer ResearchUK, Danish Cancer Society, Dr Mildred Scheel Foundation/Deutsche Krebshilfe (Germany),Dutch Cancer Society, Finnish CancerSociety, French National LeagueAgainst Cancer, Israel CancerAssociation, Italian Association forCancer Research, National CancerInstitute of Canada/Canadian CancerSociety, National Cancer Institute(USA), Swedish Cancer Society

International OncologyNursing Fellowships (IONF)Duration: one monthTarget group: qualified registerednurses or nurse educators in lowor middle-income countriesAim: to facilitate observerships on aspects of cancer education,patient counselling, palliative care and similar at renowned comprehensive cancer centresabroad.Sponsors: Association of UICCFellows, ONS Foundation,Oncology Education Services,Oncology Nursing CertificationCorporation, Oncology NursingSociety (USA)

Asia-Pacific Cancer SocietyTraining Grants (APCASOT)Duration: one weekTarget group: staff or accreditedvolunteers from voluntary cancersocieties in the Asia-Pacific regionAim: to develop cancer controlcapacity in the Asia-Pacific region.Sponsors: William RudderMemorial Fund (Australia)

In 2003, UICC allocated a total of 131 Fellowships:• 3 TCRF • 7 ACSBI • 14 YY• 91 ICRETT• 2 Reverse ICRETTs• 10 IONF• 4 APCASOT

Outstanding scientist contributes to prostate cancer researchIn 2003, Dr Daniel Wreschner, a researcher at the Department of Cell Research and Immunologyat the University of Tel-Aviv, Israel,was awarded a UICC TranslationalCancer Research Fellowship thattook him to the Laboratory ofMolecular Biology (Division of Cancer Biology) of the USNational Cancer Institute inBethesda, Maryland.

During a one-year UICC Fellowship,he identified a new gene implicatedin prostate cancer. He was calledan “outstanding scientist”, by his host supervisor at his Novartisfellowship. The one-year Translational Cancer ResearchFellowship was funded by Novartis(Switzerland).Under the supervision of Dr IraPastan, Dr Wreschner made ahighly significant contribution tothe lab’s ongoing Gene Discoveryprogramme, identifying a newfamily of genes expressed in malereproductive tissues. He also initiated the production of animportant new immunotoxin.While Dr Wreschner has nowcompleted his Fellowship, the USand Israeli research institutions arecontinuing to collaborate on bothprojects.

The Association of UICCFellows

Membership of the Association ofUICC Fellows jumped sharply from500 to some 900, thanks to timelychanges to the fee structure thatnow entitles Fellows to lifetime,rather than annually-renewable,membership. Membership is subject to successful completion ofa UICC Fellowship.

Katrina Horvathova, Cancer ResearchInstitute, Bratislava, Slovak Republic, wasan ICRETT Fellow 2003 at the ClinicalInstitute of Medical and ChemicalLaboratory Diagnostics, University ofVienna, Austria.

Ms G. Humagai, IONF Fellowship 2003,with colleagues.


Nursing and cancer careUICC continues to develop its new Basic Cancer Nursing Courseonline resource, a collection ofbest practices for nursing cancerpatients targeted at low-to-middleincome countries. Based on theOncology Nursing Society (ONS)Manual for Oncology Nurses, thecourse has been revised and adaptedby UICC for the developing world,and is scheduled for pilot testing inIndia, Panama, Poland, Singaporeand South Africa during 2004.

In addition, every year UICC awards10-15 International OncologyNursing Fellowships (IONF) valuedat US$2,800. The month-longFellowship courses are open toqualified nurses or nurse educatorsactively engaged in the care ofcancer patients. Courses covercancer education programmes for prevention and early detection,patient counselling, safe drug handling, palliative care, painassessment and quality of lifeissues. UICC awarded 10 IONFFellowships in 2003.

TNM ClassificationNew approach to a ground-breaking UICC publicationUICC’s renowned TNM Classification,launched over 50 years ago, is thegold standard for classifying theanatomic extent of tumours (stag-ing), allowing medical practitionersanywhere in the world to assesstumours according to standarddescriptors, which form the bases of appropriate treatment.

UICC’s TNM series, which includesthe TNM Classification, Supplement,Atlas and Prognostic Factors inCancer, is under continuous reviewto take into account developments indiagnosis and management. TheTNM Core Group of fourteenexperts launched an initiative toincrease the number of TNMNational Committees from 10 to20. Their Chairs make up the TNMGlobal Advisory Group that in turnsupports the TNM Core Group forfuture editions of the TNM seriesof publications.

The TNM publications are availablein book format and, since 2003,online. The TNM project is fundedby the US Centres for DiseaseControl and Prevention (CDC - see www.cdc.gov).TNM Classification ! accuratediagnosis!appropriate treatment !survival

Objectives of the TNMClassification• To aid clinicians with diagnosis

and planning treatment • To give an indication of prognosis• To assist in evaluating treatment

results• To facilitate information exchange

between treatment centres• To contribute to further

investigations of human malignancies

Continuous improvement of TNM• change of staging criteria • clinical relevance: assessment,

treatment, and outcome • evidence for improved

prognostic ability• evaluation by site-specific panels

of experts and TNM national committees

• acceptance by members of the UICC TNM Core Group

UICC PublishingPartnershipIn May, 2003 UICC and its partner,global publisher John Wiley andSons launched TNM Online, an electronic database providingmedical oncologists, radiationtherapists, oncology surgeons andother cancer professionals with

one-stop, online access to essentialinternational standards for assessingthe diagnosis, treatment andprognosis of cancer patients.Presented as part of Wiley Inter-science (www.interscience.wiley.com),Wiley’s internet-based publishingplatform, TNM Online combinesthe full content of several key UICCreference sources. Latest figuresshow daily hits to the homepagenow average around 200.

In hard copy format, the 6th editionof the UICC TNM Classification isnow available in French, German,Japanese, Russian, Slovak, andSpanish, with further languages – Chinese, Portuguese, Czech,Georgian, Polish, Romanian,Hungarian, Greek and Arabic – in the pipeline. The 3rd edition of the TNM Supplement appeared inSeptember 2003, and UICC is nowin the process of finalising the 8th edition of the Manual ofClinical Oncology.

Global publisher John Wiley andSons is a longstanding UICC business partner. The companypublishes UICC’s flagship journalthe International Journal of Cancer,as well as the TNM Classificationof Malignant Tumours, the TNMSupplement, TNM Atlas andPrognostic Factors in Cancer. WileyInterscience is one of the world’sleading providers of online scientific,technical, and medical content.

International Journal of CancerUICC’s prestigious InternationalJournal of Cancer (Chief Editor Dr H. zur Hausen) remains theworld’s leading reference for originalpapers and review articles onexperimental and clinical cancerresearch. Distinguished by its publication of epidemiologicalstudies from around the world, the Journal concentrates on fundamental issues relevant to the understanding and effectivetreatment of human cancer. A further five volumes appeared in 2003, while the Journal’s impactfactor, a key indicator of readershipand influence, increased to 4.375,up from 4.056 in 2002.

UICC’s 12th Reach to RecoveryInternational (RRI) Breast CancerSupport Conference took place inLisbon, Portugal in May 2003,hosted by Vencer e Viver and thePortuguese Cancer League.

The conference welcomed 340delegates from 45 countries, andfor the first time featured significantrepresentation from Central andEastern Europe and Africa. Anambitious four-day programmeincluded sessions on communication,information, and advocacy, alongwith science and treatment, whileround table discussions addressedissues including breast cancer inyoung women and strategies forrecruiting and retaining volunteers.

Awards at RRI Lisbon 2003Teresa Lasser AwardEstablished by the AmericanCancer Society, the Teresa LasserAward recognises outstanding volunteers who introduce, initiateand contribute to the developmentof Reach to Recovery breast cancer support programmes in theircountries. This year’s award waspresented to Henriette Nesbitt deAlmeida Lima, founder of Vencer e Viver in Lisbon.

Reach to Recovery International MedalDr Rajendra A. Badwe, Head ofthe Department of Surgery, TataMemorial Hospital, Mumbai, India,was the recipient of this year’s RRI Medal for encouraging voluntary breast cancer supportprogrammes, particularly V Careand the Mastectomees Associationin India.

Regional breast cancer survivorconferences are an important partof Reach to Recovery International, with the 1st Asia-Pacific RRI BreastCancer Support Conference heldin Kuala Lumpur from 8-11 August2002, attracting participants frombreast cancer patient and survivor support groups, as well as breastcancer advocacy groups.


Capacity BuildingReach to Recovery International: supporting the global fight againstbreast cancer. With a network of 70 groups in 50 countries, Reach toRecovery International (RRI) is a worldwide UICC programme aimed at fostering exchange between national, regional and global Reach to Recoverybreast cancer patient support and advocacy groups.

Reach to Recovery International Group,Portugal.


A survivor’s story:Gladys Boateng “Having had a life-changing experience with Reach to Recovery,I am now very eager to share mypositive outlook with other breastcancer patients,” says Ghanaiansurvivor Gladys Boateng.

Gladys was diagnosed with breastcancer in 1999. Her first encounterwith Reach to Recovery was inhospital in Johannesburg, whereshe had undergone a total mastectomy of the right breast.Lying in bed, she overheardanother patient say that thespread of cancer to one of Gladys’lymph nodes meant her conditionwas fatal.

“By the time the volunteer fromReach to Recovery South Africacame to visit me, I was feelingvery fearful and downcast,” saysGladys. “Her visit brought meincredible relief and hope.”

A subsequent Reach to Recoverysupport meeting proved an eye-opener for Gladys, who met otherwomen who had had lymph nodetumours yet who were in goodhealth. Back in Ghana, she sawthat many women fail to seekmedical advice until too late,

because they regard treatmentas merely prolonging thesuffering of a conditionerroneously perceived as a death sentence.

Gladys’ story of survivalspurred her to contact RRIat UICC in Geneva. She isnow training as a Reach toRecovery volunteer, armedwith a message of comfort

and hope.

Developing national cancer control plansPartnering with WHO toachieve cancer control goalsWell-conceived, well-managedNational Cancer Control Programmes(NCCP) lower cancer incidenceand improve the quality of life ofcancer patients and their families.They also help policy-makers andplanners allocate resources in waysthat benefit the entire population,with a focus on evidence-basedstrategies for prevention, earlydetection, and palliative care.

Few comprehensive NCCPs existtoday. Where they do, they arerarely fully implemented, withtreatment-oriented approachesaccorded preference over primaryprevention, early detection andpalliative care. As part of its effortsto move cancer onto the globalagenda, UICC has joined forces withthe World Health Organization toencourage countries to developand implement effective NCCPs.

In parallel, UICC also launched a project to create an internationaldirectory of NCCPs. This directorywill provide a much-needed complement to WHO’s publicationon National Cancer ControlPlanning, which serves as a toolfor enabling countries to carry outself assessment. As a next step,UICC has completed a first draftof a “How To” guide outlining the practical questions healthauthorities need to consider whenundertaking WHO-compliant cancer control planning.

Regional workshops on strategicplanning, with a particular emphasison prevention and early detection,are an important component ofthis activity, with the 2003 KualaLumpur workshop attracting participants from Ministries ofHealth, Cancer Societies andCancer Institutes from throughoutthe region. Participants focused onthe development of appropriatestrategies for screening for breastand cervical cancer for developingcountries in the region andexplored approaches to primaryprevention of, and education

about, women’s cancers whichwould be applicable across diversecultural and resource settings.UICC also participated in the AsiaPacific Organisation for CancerPrevention (APOCP) conferenceheld in Nagoya, Japan, and held asymposium entitled Asian CancerPrevention – Today and Tomorrow.

Alliance for Global Cancer ControlTwo priorities emerged from thedeliberations of 60 cancer controlleaders at the Chicago meeting of the Alliance for Global CancerControl, hosted by the AmericanSociety of Clinical Oncology(ASCO) and the ACS in June,2003. The first is the need to firmly establish cancer control on global and economic healthagendas; the second, to campaignfor broader public awareness ofcancer-related issues.

Alliance members also gathered atthe August 2003 World Conferenceon Tobacco or Health in Helsinki,Finland. At this meeting, more than30 organizations signed a firstpublic statement committing themto accept and share responsibilityfor the worldwide implementationof the WHO Framework Conventionon Tobacco Control.

Launched in 2003, the Alliance for Global Cancer Control is a jointinitiative of UICC and the WorldHealth Organization, drawingmembers from government, NGOsand private industry and from disciplines including medicine,nursing, scientific research, publichealth, and communications.

Non-communicable disease (NCD),in particular cancer, cardiovasculardisease and diabetes, are majorcauses of death worldwide. UICCis actively developing global andnational alliances for the preventionof NCD caused by tobacco,unhealthy nutrition and physicalinactivity.

Global Action Against CancerWith its partner the World HealthOrganization, UICC co-publishedGlobal Action Against Cancer,an overview of the worldwide incidence, mortality, and prevalenceof cancer for the launch of theGlobal Alliance Against Cancer.The publication is available free of charge in English in hard copyand online, with an accompanyingslide presentation.

Cancer SurvivorshipUICC and the Lance ArmstrongFoundation put spotlight oncancer survivorshipUICC participated in a specialpress conference in Paris in thewake of Lance Armstrong’s fifthconsecutive Tour de France win.The aim of the event, hosted bythe Lance Armstrong Foundation(LAF – www.laf.org) and the UnitedStates President’s Cancer Panel(PCP – http://pcp.cancer.gov),was to increase cancer awareness,encourage people to talk aboutcancer, and reduce the stigma surrounding the disease.

Participants included LanceArmstrong, PCP Chair Dr LaSalleD. Leffall Jr, French oncologist Dr David Khayat, Ms PascaleBriand, the head of the FrenchInterministerial Commission on Cancer, Dr Andrew C. vonEschenbach, Director of the USNational Cancer Institute, Dr Pujol, President of the FrenchCancer League and Reach toRecovery International memberMaria Cunha from Portugal.

The term “cancer survivorship”covers a variety of quality of lifeissues confronting survivors, ranging from practical matters to emotional support from familyand friends. A number of cancer survivors and cancer organisations joinedUICC, the Lance ArmstrongFoundation and President’s Cancer Panel at the event, including the French Federation of Comprehensive Cancer Centres,UICC’s Reach to RecoveryInternational, the group l’ENVOLpour les Enfants Européens, andthe French League Against Cancer.

Hope LodgesCaring for the practical andemotional needs of patientsCancer patients in many countriesare often faced with formidablepractical hurdles, such as the distance to treatment centres andthe prohibitive costs of hospitalstays and palliative care. In addition, patients and their families frequently suffer a chroniclack of moral and psychologicalsupport.

In 2003, UICC launched a projectto develop guidelines for creatingHope Lodges. These centres, whichalready exist in some countries,help resolve practical problems by allowing patients to undergotherapy as outpatients at little orno cost for room and board, andby offering the benefits of sharedexperience with fellow patientsand, in some cases, professionalpsychological support.

UICC has initiated efforts to raiseawareness of Hope Lodges as low-cost temporary accommodationfor cancer patients and their familiesnear treatment centres. A guide-book is being developed withmodels for different resource settings.

Fundraising, media relations and volunteermotivationUICC Asia Pacific Fellowshipfocuses on voluntary cancersocietiesAsia-Pacific Cancer Society TrainingGrants (APCASOT) are a joint project between UICC and TheCancer Council Australia aimed at developing cancer controlcapacity in the region through the establishment of voluntarycancer societies.

Generally of one to two weeks’duration, the Fellowships involvehost organisations inviting anoverseas Fellow to take part in a project in the field of fundraising,media relations or volunteer motivation. Eligible candidates arestaff of accredited voluntary cancersocieties; participating countriesinclude Australia, Singapore andIndia. Four APCASOT Fellowshipswere granted in 2003.

Relay For LifeAfter formally establishing theInternational Relay For Life programme in 2002, ACS andUICC began working together to bring Relay For Life across the world. Relay For Life, theAmerican Cancer Society’s signature activity, is an overnightevent that celebrates cancerpatients and survivors and bringscommunities together to supportthe fight against cancer througheducation, advocacy, research, andpatient services. The event raisesfunds and awareness for the battleagainst cancer.


Dr Harish Kulkarni and members of theIndian Cancer society, Nagpur, beforeleaving for APCASOT Fellowship inAustralia.


By 2003, UICC members inAustralia, Canada, England,Northern Ireland, New Zealand,Scotland and Singapore launchedtheir own versions of Relay ForLife with great success. Also during the year, preparations began in countries such asVenezuela, Israel, Hong Kong,Guatemala, Mexico, Slovenia and Argentina.

Women’s Cancer European Workshop Near the end of 2002 UICC Reachto Recovery International, togetherwith the Association of EuropeanCancer Leagues (ECL), and theOncology Centre Antwerp (OCA)hosted a workshop focused onwomen’s cancer in Europe. The goalwas to identify the current level ofpolitical activity being undertakenby cancer support groups and toencourage further action.

New research shared at SouthAfrica meetingUICC was a co-organiser of theInternational Symposium onEmerging Perspectives in ClinicalResearch held in Cape Town,South Africa, from 26-28November 2003. Presentationsconcerned four areas of cancerresearch: immunosuppression andinfection in cancer etiology; viral and bacterial influences incarcinogenesis; diagnosis andscreening of cancer; and novelsites of intervention. This meetingprovided significant new informationand gave UICC the opportunity tohelp facilitate exchange of leading-edge translational research in cancer research.

US President’s Cancer PanelUICC was invited to attend the US President’s Cancer Panel’s firstinternational meeting, held inPortugal, with the objective ofseeing if European approaches tocancer care and survival can beapplied to the US national cancer programme. The Panel heard fromcancer survivors and health careprofessionals, and the meetingwas held back-to-back withUICC’s 12th Reach to RecoveryInternational (RRI) Breast CancerConference in May 2003.

UICC conferencesOfficial and informal exchanges at UICC international conferencesare among the most efficient meansof disseminating information, stimulating new ideas, and updating concepts in the light of recent discoveries.

2003 served as a vital preparatoryyear for a number of importantupcoming events:

4th UICC World Conference forCancer OrganisationsDublin, Ireland 17-19 November, 2004Hosted by the Irish Cancer Societywww.wcco.uicc.org

UICC Conference on Challengesof Cancer in Developing CountriesCairo, Egypt21-25 March 2005

13th Reach to RecoveryInternational Breast CancerSupport ConferenceAthens, Greece 1-4 June, 2005Hosted by the Hellenic Associationof Women with Breast Cancer and the Society of Volunteersagainst Cancerwww.breastcancerhellas.gr

UICC World Cancer Congress 2006Washington DC, USA 8-12 July, 2006Hosted by the American CancerSocietywww.worldcancercongress.org

13th World Conference onTobacco or HealthWashington DC, USA 12-15 July, 2006Hosted by the American CancerSocietywww.13thWCTOH.org

UICC International Calendar of Cancer ConferencesUICC has distributed some 16,000copies of its International Calendarof Cancer Conferences, which lists major international cancer-related conferences, meetings andcongresses over a three-year period.Funded by Novartis Oncology, thecalendar is also available online atwww.uicc.org.

Relay For Life in Hobart, Australia.

One of the most important projects UICC has ever undertaken,eUICC builds on the acclaimedsuccess of our GLOBALink onlinetobacco control network. Since its launch, it has proved a highlyeffective means of delivering comprehensive, up-to-date information about UICC’s full rangeof cancer control programmes toaudiences worldwide. Benefits to members and to the global cancer control community includebetter access to and sharing ofresources, improved coordinationof activities, and greater mobilisationtowards agreed policies.

Using tools such as e-mail groups,online forums, bulletin boards,web-based information, and trainingactivities, UICC is now beginningto progressively migrate many ofits initiatives towards the eUICCplatform, with the support of anACS Challenge grant.

The first round of eUICC-basedprojects includes the Network of Representatives and the development of eToolkits targetingspecific issues.

eToolkitseToolkits are Internet-based resourcesthat allow knowledge generated in one context to be understood,adapted and utilised in differentenvironments. An integral part of our strategy of encouragingmultidirectional information flows,eToolkits promote the sharing ofmodels of best practice and localsuccess stories.

The remarkable power of theInternet provides new opportunitiesfor training, for mobilization, andfor the sharing of resources, information and knowledge. While recognizing that a greatnumber of people who need information cannot access theinternet, every effort will be madeto ensure UICC’s presence on theinternet in the form of eUICC.


New HorizonsUICC is actively working to adapt to meet the evolving needs ofpatients and the global cancer community. The enormous potential of modern information and communication technologies such as the Internetto serve as an effective vehicle for exchanging information and promotingUICC programmes prompted the launch in 2003 of a powerful new globalinformation and communications network known as eUICC.


UICC governance and membershipThe UICC Executive Commitee hasalso been focusing much attentionon ways and means of streamlininginternal decision-making structuresand operations, and on definingnew membership formats that better respond to the demands of today’s organisation.

In late 2003, UICC President Dr John Seffrin appointed aMembership and Governance Task Force. Chaired by Dr MaryGospodarowicz, the group lookedclosely at current UICC operationsand developed a series of recommendations for modifyingUICC membership and governingstructures.

The proposed changes, slated for implementation in 2006,include holding the UICC WorldCancer Congress and GeneralAssembly every two years. In addition, a two-tier governancestructure comprising the GeneralAssembly and a Board of Directorswould be introduced. A specialExtraordinary General Assemblyhas been called for November2004 to vote on these proposals.

UICC signs Memorandum of Understanding with WorldHeart FederationUICC signed a three-yearMemorandum of Understanding(MoU) with partner public healthorganisation the World HeartFederation in May, 2003 aimed at promoting awareness of common risk factors for non-

communicable diseases such ascancer and cardiovascular

disease. Plans are alsounderway for joint campaigns in the fieldsof nutrition, exercise

and tobacco control inlow and middle-incomecountries.

In addition, the two organisationsjoined forces on World No TobaccoDay (31 May, 2003) to drawattention to the dangers of second-hand smoke. According to some estimates, non-smokerswho regularly breathe second-handsmoke have a 25 percent increasedrisk of developing both lung cancerand heart disease, and an 80 percentincreased risk of stroke.

For a smoke-free world The World Heart Federation is a Geneva-based NGO dedicatedto the prevention and control ofcardiovascular diseases. Together,UICC and the Federation aremobilising their combined member-ships of over 450 organisations inmore than 100 countries to lobbygovernments, health authoritiesand employers to introducesmoke-free measures (smoke-freehospitals, workplaces, restaurants,public transport and so on), and to train health professionals toeducate communities about therisks of second-hand smoke andthe immediate health benefits for smokers who quit.

International CancerFoundation – supporting cancer control and cancer care worldwideThe UICC International CancerFoundation, ICF, was created in 1971 to support the vision, mission, and work of UICC. ICFmakes grants exclusively to UICCin support of ongoing programmesthat raise the standards of cancercontrol and cancer care throughoutthe world. ICF links donors whowant to join the fight against cancerwith philanthropic opportunities.


Liga Argentina de Lucha Contra el CáncerCancer Council ACTCancer Council AustraliaCancer Council New South WalesCancer Council Northern TerritoryCancer Council South AustraliaCancer Council TasmaniaCancer Council VictoriaCancer Foundation of Western AustraliaNational Cancer Control InitiativePeter MacCallum Cancer InstituteQueensland Cancer FundWalter & Eliza Hall Institute of Medical ResearchBahrain Cancer SocietyBangladesh Cancer SocietyBelgian Federation Against CancerOncologic Center AntwerpFundación Boliviana Contra el CáncerAssoc. Brasileira Assistencia aos CancerosFundacao Oncocentro de Sao PauloGrupo Brasileiro de Estudos do CancerINCA Instituto Nacional do CancerInstituto Brasileiro de Contrôle do CâncerLiga Bahiana Contra o CancerSociedade Brasileira de CancerologiaUniversity of Sao PauloBritish Columbia Cancer AgencyCanadian Cancer SocietyCancer Care OntarioCentre for Chronic Disease and Prevention ControlFondation Québécoise du CancerNational Cancer Institute of CanadaUniversity Health Network, Princess Margaret HospitalChinese Anti-Cancer AssociationChinese Medical Association - BeijingHong Kong Anti-Cancer SocietyTianjin Medical University Cancer Inst. & HospitalLiga Colombiana Contra el CáncerCroatian League Against CancerInstituto Nacional de Oncología y RadiobiologíaCyprus Anti-Cancer SocietyCyprus Association of Cancer Patients & FriendsLeague Against Cancer PragueDanish Cancer SocietyLiga Dominicana Contra el CáncerPatronato Cibaeño Contra el CáncerSociedad de Lucha contra el CáncerFakkous Center for Cancer and Allied DiseasesNational Cancer Institute - CairoInstituto del Cáncer de El SalvadorEstonian Cancer SocietyFiji Cancer SocietyCancer Society of FinlandCentre Antoine LacassagneCentre d'Oncologie Léon BérardCentre Georges-François LeclercCentre Rég. de Lutte contre le Cancer Paul StraussCentre Régional François BaclesseCentre Régional Jean PerrinCentre Régional Paul PapinCentre René-HugueninComité Départemental de l'AubeComité Départemental de la SavoieComité Départemental des Hauts-de-SeineComité Départemental des YvelinesComité Nationale pour les Relations avec l'UICCCRLCC Centre Régional René GauducheauEpidaure C.R.L.C. Val d'Aurelle-Paul LamarqueFédération Nationale des Centres de Lutte contre le CancerInstitut Claudius Regaud

ArgentinaAustralia

BahrainBangladesh

Belgium

BoliviaBrazil

Canada

China

ColombiaCroatia

CubaCyprus

Czech RepublicDenmark

Dominican Republic

EcuadorEgypt

El SalvadorEstonia

FijiFinlandFrance

Global Activities

France

Germany

Greece

GuatemalaHonduras

HungaryIceland

India

IndonesiaIran

IrelandIsraelItaly

Japan

Institut CurieInstitut Gustave RoussyInstitut Jean-GodinotInstitut Paoli CalmettesLigue Nationale Comité de ParisLigue Nationale Contre le CancerSociété Française du CancerDeutsche Krebsgesellschaft e.v.Deutsche KrebshilfeDeutsches KrebsforschungszentrumWestdeutsches TumorzentrumHellenic Cancer SocietyHellenic Society of OncologyLiga Nacional Contra el Cáncer Guatemala / PiensaAsociación Hondureña de Lucha contra el CáncerLiga Contra el Cáncer - HondurasHungarian League Against CancerIcelandic Cancer SocietyBangalore Institute of OncologyCancer Centre Welfare Home and Research InstituteCancer Institute (WIA)Cancer Patients Aid AssociationDharamshila Cancer Hospital and Research CentreDr B. Borooah Cancer InstituteGujarat Cancer & Research InstituteIndian Cancer SocietyInstitute of Cytology & Preventive OncologyIRCH Institute Rotary Cancer HospitalKidwai Memorial Institute of OncologyMeherbai Tata Memorial HospitalTata Memorial CentreIndonesian Cancer FoundationCancer Institute, Imam Khomeini Medical CenterResearch Center of Gastroenterology & Liver TransplantationShariati Hospital HORCIrish Cancer SocietyIsrael Cancer AssociationAIOM Associazione Italiana di Oncologia MedicaAssociazione Italiana Malati di Cancro parenti ed amiciAssociazione Italiana Ricerca sul CancroCentro di Riferimento Oncologico, Istituto Nazionale Tumori, IRCCSCentro per lo Studio e la Prevenzione OncologicaEuropean Institute of OncologyEuropean School of OncologyIST Istituto Nazionale per la Ricerca sul Cancro - Universitàdi GenovaIstituto di Ricerche Farmacologiche "Mario Negri"Istituto Nazionale per lo Studio e la Cura dei TumoriIstituto Nazionale per lo Studio e la Cura dei Tumori.Fondazione "G. Pascale"Istituto Oncologico RomagnoloLega Italiana per la Lotta contro i TumoriRegina Elena Cancer InstituteUniversita degli Studi dell' InsubriaUniversità degli Studi di PerugiaAichi Cancer CenterCancer Institute of JFCRChiba Cancer CenterChildren's Cancer Association of JapanFukuoka Cancer SocietyHokkaido Cancer SocietyInstitute of Cellular & Molecular BiologyJapan Cancer SocietyJapan Foundation Multidisciplinary Cancer TreatmentJapan Lung Cancer SocietyJapan Society of Clinical OncologyJapanese Cancer AssociationJikei University School of MedicineKanagawa Cancer CenterMiyagi Cancer Society


Japan

JordanKenya

Korea (South)

KuwaitLatvia

LebanonLithuania

LuxembourgMalaysia

Mexico

MongoliaNamibia

NepalNetherlands

New ZealandNigeria

NorwayOman

Pakistan

Panama

Peru

PhilippinesPoland

Portugal

RomaniaRussia

Saudi ArabiaSerbia and Montenegro

SingaporeSlovakia

South AfricaSpain

Sweden

SwitzerlandSwitzerland

Nagoya Memorial HospitalNational Cancer Center - JapanOsaka Cancer FoundationOsaka Medical Center for Cancer & Cardiovascular DiseasesPrincess Takamatsu Cancer Research FundSaitama Cancer CenterSapporo Cancer Seminar FoundationSasaki Institute and FoundationScience Council of JapanTochigi Cancer CenterTokyo Metropolitan Komagome HospitalKing Hussein Cancer CenterKenya Cancer AssociationKorea Cancer Center HospitalKorean Cancer SocietyNational Cancer Center Research InstituteKuwait Society for Smoking and Cancer PreventionAugust Kirchenstein Institute Microbiology & VirologyLebanese Cancer SocietyLithuanian Anti-Cancer AssociationMinistère de la Santé - LuxembourgCancer Society of Sabah MaknaNational Cancer Society of MalaysiaAsociación Mexicana de Lucha Contra el Cáncer A.C.Instituto Nacional de Cancerología - MéxicoSociedad Mexicana de Estudios Oncológicos, A.C.National Oncological Centre, MongoliaCancer Association of NamibiaB.P. Koirala Memorial Cancer HospitalNepal Cancer Relief SocietyAcademisch Medisch CentrumDutch Association of Comprehensive Cancer CentersDutch Cancer SocietyNetherlands Cancer InstituteCancer Society of New Zealand, Inc.Nigerian Cancer SocietyNorwegian Cancer SocietyMinistry of Health - Sultanate of OmanMinistry of Health - Pakistan SecretariatPakistan Atomic Energy CommissionAsociación Nacional Contra el CáncerInstituto de Enfermedades NeoplásicasLiga Peruana de Lucha Contra el CáncerOncosalud SACSociedad Peruana de CancerologíaSociedad Peruana de Oncología MédicaPhilippine Cancer SocietyInternational Hereditary Cancer CenterPolish Oncological Society - CracowInstit. Português de Oncologia de Francisco Gentil, Centro Regionalde Oncologia de Coimbra, SALiga Portuguesa Contra o CancroInstitute of Oncology "Al Trestioreanu" BucharestN.N. Blokhin Cancer Research CenterN.N. Petrov Research Institute of OncologyMinistry of Health - Saudi ArabiaSerbian Society for the Fight Against CancerNational Cancer Center - SingaporeSingapore Cancer SocietyLeague Against Cancer in SlovakiaAssociation of Slovenian Cancer SocietiesInstitute of Oncology LjubljanaCancer Association of South AfricaAsociación Española Contra el CáncerAsociación Vivir Como AntesInstitut Català d'OncologiaCancer Society in StockholmSwedish Cancer SocietyKrebsliga SchweizLudwig Institute for Cancer Research - Zurich

SyriaTaiwan

Thailand

Trinidad and TobagoTunisia

TurkeyUK

Uruguay

USA

VenezuelaVietnam

Zimbabwe

Syrian Cancer SocietyChinese Oncology SocietyFormosa Cancer FoundationTaiwan Cancer SocietyNational Cancer Institute - ThailandThai Cancer SocietyTrinidad & Tobago Cancer SocietyAssociation Tunisienne de Lutte contre le CancerInstitut Salah AzaizTurkish Association for Cancer Research & ControlBritish Association for Cancer ResearchBritish Association of Surgical OncologyCancer Research UKCancer Research UK Beatson LaboratoriesCancerBACUPCochrane Cancer NetworkInternational Institute of Cancer ResearchInternational Ostomy AssociationLudwig Institute for Cancer Research - LondonMacmillan Cancer ReliefMarie Curie Cancer CarePaterson Institute for Cancer ResearchTenovus Cancer CharityUlster Cancer FoundationComisión Honoraria de Lucha contra el CáncerHospital de Clínicas "Dr Manuel Quintela".Albert C. & Bertha P. Markstein CancerAmerican Association for Cancer ResearchAmerican Cancer SocietyAmerican College of RadiologyAmerican College of SurgeonsAmerican Head and Neck SocietyAmerican Society of Clinical OncologyArthur G.James Cancer Hospital Research InstituteAmerican Society of Therapeutic Radiology OncologyCabrini Medical CenterCampaign for Tobacco-Free KidsCenters for Disease Control & PreventionCollege of American PathologistsFred Hutchinson Cancer Research CenterGerald P. Murphy Cancer FoundationH. Lee Moffitt Cancer CenterHuntington Medical Research InstituteInternational Society Study Comparative OncologyKellogg Cancer Care CenterM.D. Anderson Cancer CenterMassey Cancer CenterNational Cancer Institute - USANational Center for Tobacco-Free KidsOncology Nursing SocietyRoswell Park Cancer InstituteSociety of Surgical Oncology Inc.Sociedad Anticancerosa de VenezuelaNational Cancer Institute - VietnamCancer Association of Zimbabwe

UICC Members


List of MembersAoki, KunioAsh, CarolBaity, JohnBalmain, AllanBarrett, AnnBeltran Ortega, ArturoBrawer, MichaelBrien, GraemeBrzakovic, PredragBurger, MaxBurn, IBurton, RobertCaceres, EdouardoCaligaris-Cappio,FedericoCerutti, PCharlton, AnneCiechanover, A.Cleaver, J.Cleton, F.Cognetti, FrancescoCollan, YrjöCollins, V.Das, Samirande Amesti, F. de Garcia Granados, E.de Nuñez, Isabel Denis, LouisDiehl, V.Dietel, M.Dillner, JoakimDinshaw, KetayunEckhardt, SandorElovainio, L.Estevez, RobertoFlamant, R.Furman, J.Grammatica, L.

Gray, NigelGreene, TrishGrivegnée, AndréGupta, PrakashHakama, MattiHanks, GeoffreyHann, ByronHansen, H.Heppner, GloriaHirayama, T.Höffken, K.Höfler, H.Hoskins, WilliamHutter, RobertIhse, IngemarImai, KohzohJonas, A.Junqueira, AntonioKasdorf, HelmutKavanagh, JohnKikuchi, KokichiKim, Hoon-KyoKim, Jin-PokKrasna, Mark Kurihara, MinoruKurkure, ArunLasser, PhillippeLawrence, WalterLenhard, RaymondLevin, B.Lipatov, GeorgyLise, MarioLittbrand, BoLlombart-Bosch, A.Lucas, G.Magrath, I.Mayer, Zaharia Metcalf, DonaldMickelson, H. Fred

Mihich, EnricoMirand, EdwinMittra, IndraneelMiwa, M.Morgan, MichaelMurphy, GeraldMusé Sevrini, I.Muto, T.Nambiar, RajNemez, LuisaNilsson, KennethNister, MonicaOmar, SherifOspina, J.Pavlovska, IrinaPeters, L.Pontén, J.Ragde, H.Rajewsky, ManfredRingborg, UlrikRobinson, EliezerRosenthal, DavidRudolf, ZvonimirRuiz de Campos, LissethRutqvist, L.Sasaki, RyuichiroSchmidt, C.Seffrin, J.Sekhar, LaligamSenn, HansShah, JatinSheldrick, P.Sobin, LeslieSoedoko, RoemwerdinjadiSriplung, HutchaSrivastava, P.Stanbridge, E.Stanley, E.Storme, G.

Sugarbaker, PaulTaguchi, TetsuoTahara, EiichiTang, Zhao-YouTattersall, MartinThomas, JoséTominaga, SuketamiToyoshima, K.Trainin, N.Trichopoulos, D.Tsuchida, NobuoTsuruo, TakashiUjhazy, V.Ullrich, Axelvan der Walt, Rika van Wyk, C.Vazquez Rosas, TabareWada, T.Weber, WalterWilkinson, PhilipWilkinson, SusieWoelkers, JosephWyke, JohnXu, GuangYuile, P.Zaridze, Davidzur Hausen, Harald

UICC Roll of HonourThrough the Roll of Honour, UICC and its member organisations recognise and acknowledge the outstanding commitment and achievements in the fightagainst cancer of individuals throughout the world. As individual members ofUICC, these distinguished scientists, clinicians, care professionals and volunteerssupport UICC activities with an annual membership donation of $250. All UICCmember organisations are encouraged to honour the outstanding achievementsof their own staff and volunteers by sponsoring them for Roll of Honour membership and assuming their annual donation. In 2003 Roll of Honourfunds went to support UICC activities in Prevention and Early Detection,GLOBALink and Reach for Recovery International.


Task Forces

Prevention and Early Detection Strategic Leader: Dr HélèneSancho-Garnier (all sub groups)

Strategic Direction Steering GroupDr Basil Bloch Dr Robert Burton Dr Max ParkinDr Karen Slama

Cancer Registration Task ForceDr Mokhtar Hamdi-CherifMrs Martha Oliva Dr Paola Pisani Dr Roberto ZanettiDr Max Parkin

UICC Handbook on Evidence-Based Cancer PreventionStrategies Task ForceProf. Annie Anderson Dr Andy Biedermann Dr Elsebeth LyngeDr Karen Slama

Promoting Evidence-BasedInterventions Task Force Dr Arun KurkureDr Lisseth de Campos Dr Maria Paula CuradoDr Catterina FerrecioDr Marion Pineros Petersen

Oversight Committee UICCLatin America Cervical CancerPilot ProjectDr Basil Bloch Dr Eduardo CaceresDr Stener KvinnslandMrs Martha OlivaDr Carlos SantosDr Odd Soreide

Tobacco ControlStrategic Leader: Mr YussufSaloojee (all sub groups)

Tobacco Control MembershipWorking Group 2003Dr David BristolMr Mike DaubeMr Liisa ElovainioTom GlynnNigel GrayDr Prakash Gupta Mr Andrew Hayes Dr Albert Hirsch Ms Jean King Mr Ken KyleMr Fred MickelsonDr Sherif OmarMr Mike Pertschuk (ex officio) Ms Denise SullivanDr Witold Zatonski Ms Miri Ziv

GLOBALink Tobacco ControlWorking GroupDr Simon ChapmanDr Alex JadadDr Sinead JonesMs Sylviane RatteMr David Simpson

Vision/Issue Working GroupMs Cynthia Callard Ms Shoba JohnMr Luk Joosens Mr Matth MyersMr Mike Pertschuk Mr David SweanorProfessor Ken Warner Ms Judy Wilkenfield

Knowledge TransferStrategic Leader: Dr KennethNilsson

Knowledge Transfer SteeringGroupDr Kenneth NilssonDr Mary Gospodarowicz Dr Arun KurkureDr Peter KrammerDr Raphael PollockDr Susie Wilkinson

UICC Fellowships – ACSBI,TCRF, YY Selection/Review Task ForcesDr Kenneth NilssonDr Paolo BoffettaDr Federico Caligaris-CappioDr Yuk-Ming Dennis Lo Dr John William Eley Dr Jeff EvansDr Joe HarfordDr Nicol KeithDr Boris P. Kopnin Dr Doriano FabbroDr Kohei Miyazono Dr D. Robins Dr Curzio Rüegg Dr John Stevens Immediate Past/Incoming ACSPresident

UICC Fellowships – IONFSelection Task Force Mr Dennis PyritzMs MyrnaMcLaughlin AndersonMs Emily AngMrs Sabine Perrier-BonnetDr Malgosia E. KrasuskaMrs Myrna McLaughlinAndersonMs Pearl MooreDr Susie Wilkinson

UICC Fellowships – APCASOTSelection Task ForceMr Jeff Dunn Dr A. S. CoatesDr L.J. De SouzaMs Alka KapadiaDr Antonio H. VillalonDr Korina Waibuta

UICC Fellowships – Reviewers Task ForceDr Matti AaproDr Neil AaronsonDr Garry AbelevDr Eric AboagyeDr Andreas AdamDr Hans-Olov AdamiDr Malcolm AdamsDr Clement AdebamowoDr Dillip AgarwallaDr Michael AgrezDr Wynne AherneDr Karin AhlbergDr Sam AhmedzaiDr M. AitchisonDr R. AkhurstDr Kari AlitaloDr J. AllenDr Kathryn AllenDr Neil AndersonDr Ingvar AnderssonDr Leif AnderssonMs Emily AngDr David ArgyleDr Alison ArmourDr Arja AroDr Shigetaka AsanoDr Johan AschanDr Dan AshDr Margaret AshcroftDr Alan AshworthMs Mary AssuntaDr Mariya AuerspergDr J. AustDr Herman AutrupDr D. Averill-BatesDr Hava AvrahamDr Baffour AwuahDr M. AyyangarDr Malcolm BagshawDr K BagshaweDr Jesme BairdDr Andy BakerDr Allan BalmainDr J. Bar-ZivDr R. BarrDr Margery BarrandDr Peter Barrett-LeeDr Rolf BarthDr J. BartlettDr Desmond BartonDr Ian BeavonDr M. BeckDr R. BegentDr Colin BegleyDr Uziel BellerDr Arturo Beltran Ortega

Dr Roland BergerDr J. BerghDr Jaques BernierDr A. BernsDr M. BerridgeDr Lev BersteinDr Joseph BertinoDr Istvan BesznyakDr Christer BetsholtzDr Peter BeverleyDr Roy BicknellDr Margaret BidmeadDr Jillian BirchDr Adrian BirdDr Tim BishopDr D. BlackDr George BlackledgeDr Aaron BlairDr Peter BlakeDr Maria BlascoMs Emily BleimundDr Judith BlissDr A. BoddyDr Liesbeth BoersmaDr Paolo BoffettaDr G. BomanDr T. BoonDr Cristina BosettiDr J. BothaDr Penelope BouziotisDr David BowtellDr J. BoydDr Marie BoydDr Michael BradaDr Maria BrandiDr Alexander BrehmDr Harold BrennerDr Malcolm BrennerDr David BrewsterDr Bryn BridgesDr Graham BrockDr Jacques BrotchiDr Robert BrownMr James BrownDr Tim BrummendorfDr Valerie BruntonDr E. BuarqueDr Jan BubenikDr Angelika BurgerDr Max BurgerDr Richard BurgettDr Rachel BurmanDr Neil BurnetDr Arsene BurnyDr C. BuschDr Edouardo CaceresDr Federico Caligaris-CappioDr David CameronDr M. CampoDr Angelo CarellaDr R. CartwrightDr Natale CascinelliDr J. CassidyDr D. CastaigneDr Webster CaveneeDr Lynn CawkwellDr Jonathan CebonDr Anne CharltonDr Marcel ChatelDr J. ChattopadhyayaDr Chen Show-LiDr John ChesterDr K. ChuDr Stefano CiattoDr Lena Claesson-WelshDr J. CleaverDr Alan CoatesDr Andrew CollinsDr V. CollinsDr H. ComberDr Suzanne ConzenDr Gary CookDr T. CookeDr Charles CoombesDr Colin CooperDr Andrej CörDr Peter CordeiroDr J. CossetDr Finbarr CotterDr Dorothy CrawfordDr Adrian CrellinDr D. CritchleyDr Ray CroucherDr Bernard CummingsDr David CunninghamDr Nicola CurtinDr Jack CuzickDr F. CuzinDr Maurizio D Incalci

Dr A. DalgleishDr R. Dalla-FaveraDr Juan DapuetoDr T. DaviesDr H. DavisDr Alison DawnDr Nicolas DayDr Giuseppe De PaloDr Theo De ReijkeDr Antonio De SallesDr Luis de SouzaDr E. De StefaniDr Adriano DecarliDr Shoukat DedharDr Charles DeehanDr Helmut DeisslerDr William DennyDr Eugene DeSombreDr Paola DeyDr Karl DhaeneDr Paola di GiulioDr Dario di LucaDr M. DiazDr V. DiehlDr Joakim DillnerDr Ketayun DinshawDr C. DiveDr Hilary DobsonDr Gerald DoddDr T. DolecekDr Donna DorowDr Julie DoughtyDr Mitch DowsettDr Mark DrummondDr Wenbo DuDr Mark DuffyDr Malcolm DunlopMr Jeff DunnDr C. EavesDr Suzanne EcclesDr Bernard EdenDr Alexander EggermontDr F. EilberDr Lea EisenbachDr Peter EkblomDr Anders EkbomDr E. El-OmarDr John EleyDr M. ElkindDr Paul EllisDr Haldun ErkalDr I. ErnbergDr Jeff EvansDr Doriano FabbroDr Marie FallonDr S. FanDr P. FarrellDr Ludwig FeinendegenDr Ian FentimanDr Manlio FerrariniDr Silvano FerriniDr Jean FeunteunDr J. FieldDr Malcolm FinbowDr Margaret FitchDr Stewart FlemingDr Brian FlynnDr James FlynnDr David FormanDr M. FrameDr Silvia FranceschiDr E. FreiDr T. FriedbergDr Juan FrontrothDr Grant FullartonDr Giulio GabbianiDr Hani GabraDr Helen GallDr G. GallagherDr John GallagherDr P. GallimoreDr Timothy GantDr Yu GaoDr Yu Tang GaoDr Silvio GarattiniDr A. GavinDr J. GazetDr Benjamin GeigerDr A. GerbauletDr A. GescherDr Osvaldo GiannottiDr Adam GiermaszDr Andrew GiffordDr Fiona GilbertDr D. GillespieDr S. GilmourDr L. GissmannDr Rosalind Given-WilsonDr Agnes Glaus

Dr Bengt GlimeliusDr Tom GlynnDr C. GodingDr James GoingDr David GoldgarDr D. GrahamDr Gerry Graham Dr William GrantDr M. GreavesDr John GreenDr P. GreenbergDr Vincent GrégoireDr P. GroomeDr Henri GrosjeanDr Alan GrundyDr Jose Guimaraes Dos SantosDr Barry GustersonDr Meral GüzeyDr Timothy HabeshawDr J. HageDr Angela HagueDr Hidde HaismaDr Neva HaitesDr S. HakomoriDr Andrew HallDr E. HallDr Janet HallDr Andrias HambardzumyanDr Michael HamblinDr S. HammarströmDr Ross HammondDr B. HancockDr Prakash HandeDr M. HanleyDr Byron HannDr Heine HansenDr K. HansonDr Adrian HarettDr Joe HarfordDr Stephen HarlandDr Clive HarmerDr A. HarnettDr Adrian HarrisDr Curtis HarrisDr Paul HarrisonDr Ian HartDr Andrea HartwigDr G HastingsDr Karin HaustermansDr Avraham HavaDr E. HayDr R. HayDr Monika HegiDr Tom HeiDr Carl HeldinDr Carl-Henrik HeldinDr Akseli HemminkiDr B. HendersonDr Jolyon HendryDr M. HenkDr Michel Henry-AmarDr Robert HerdDr Christian HerfarthDr Meenhard HerlynDr C. HerringtonDr Rodney HicksDr Ian HicksonDr Irene HigginsonDr Jerzy HildebrandDr Gunnar HillerdalDr Toshio HiranoDr Setsuo HirohashiDr Fred HirschDr Daniel HochhauserDr Malcolm HodginsDr Jan HoeijmakersDr K. HöffkenDr David HoleDr Jimmie HollandDr F. HollosyDr L. HolmgrenDr Tessa HolyoakeDr Martin HooperDr Kirsten HopkinsDr A. HorwichDr William HoskinsDr R. HrubanDr Tim HuangDr R. HuddartDr Robert HuddartMs Belinda HughesDr C. HungDr R. HunterDr Helen HurstDr Janet HusbandDr Cathy HutchisonDr Ingemar IhseDr Sadao IkedaDr M. Imamura


Dr Beat ImhofDr C. ImrieDr Kaichi IsonoDr R. IsselsDr Bhanu IyengarDr J. IzbickiDr Marja JaattelaDr M. Jacob MalatharayilDr Nicholas JamesDr R. JamesDr O. JarrettDr Ruth JarrettDr Karl JauchDr Luis Jimenez de AsuaDr D. JodrellDr Bertil JohanssonDr H. JohanssonMs Shoba JohnDr Patrick JohnstonDr Alun JonesDr Bleddyn JonesDr Christopher JonesDr Richard JonesDr Gunnar JuliussonDr Elizabeth JunorDr Antonio JunqueiraDr S. KaasaDr Zaiza KadagidzeDr Joachim KaldenDr R. KanamaruMs Alka KapadiaDr Malgorzata KarbownikDr Gertjan KaspersDr Moustapha KassemDr Fujio KasumiDr Stanley KayeDr Rehan KaziMs Nora KearneyDr W. KeithDr Lloyd KellandDr Douglas KellyDr Christopher KempMr Ewon KempDr Vincent KhooMs Jean KingDr Judith KingstonDr Roger KirbyDr David KirkDr Masaki KitajimaDr Eva KleinDr George KleinDr Veronika KlobovesPrevodnikDr Margaret KnowlesDr Alfred Knudson Dr Jorn KochDr Uwe KochDr Pasi KoivistoDr Walter KolchDr Jan KomorowskiDr Boris KopninDr Leopold KossDr Itamar KottDr F. KourilskyDr Gyula KovacsDr Eva KralikovaDr Malgosia KrasuskaDr Andris KreicbergsDr K. KrügerDr Ada KruisbeekDr Andrzej KulakowskiDr Rakesh KumarDr Abraham KutenDr Carlo La VecchiaDr Sunil LakhaniDr R. LamerzDr David LaneDr Peter LansdorpDr B. LastDr Eduardo LauraDr G. LawrenceDr Walter LawrenceDr C. Le Bousse KerdilesDr I. LeeDr Jean-Louis LefebvreDr Veli LehtoDr Steven LeibelDr J. LemerleDr R. LeonardDr Peter LevendagDr F. LéviDr Chun-Hai LiDr Anning LinDr Thomas LindahlDr Annika LindblomDr B. LindequeDr Joachim LingnerDr Thomas ListerDr Johné LiuDr Chung Lo

Dr J. LoefflerDr M. LokenDr Eugene. LukanidinDr Kuauhyama Luna OrtizDr E. LundgrenDr Anne LykkesfeldtDr A. MacarioDr D. MacDonaldMs Fiona MacGregorDr Mike MackettDr Rona MacKieDr Roger MacklisDr Krishnan Madhavan- NairDr Alicia Magarinos- BozzanoDr P. MaguireDr Robert MairsDr Giancarlo MaltoniDr Nils MandahlDr Robert ManselDr Janine MansiDr Roberto MantovaniDr Marc MareelDr G. MargisonDr Uwe MartensDr Malcolm MasonDr Phil MasonDr J. Howard MassagueDr Diane MathisDr Lynn MatrisianDr Taijiro MatsushimaDr Wolrad MattheiemDr Kewal MaudarDr Christoph MaurerDr S. Mc ArdleDr John McCaffreyDr Kenneth McCollDr E. McCullochDr A. McGowanDr Alan McKayMs Myrna McLaughlin-AndersonDr Howard McLeodDr Martin McMahonDr Rhona McMeneminDr Nigel McMillanDr Stuart McNeeDr H McQuayDr Mads MelbyeDr Hakan MellstedtDr Fredrik MertensDr Donald MetcalfDr K. MetodievDr F. MeyerDr Ralph MeyerDr E. MihichDr Bernard MijnheerDr William MillerDr Robert MilroyDr Min-Hua ChenDr André MinkenDr Edwin MirandDr Alan MitchellDr Allison MitchellDr Felix MitelmanDr Indraneel MittraDr Kohei MiyazonoDr Harsh MohanDr G. MoldenhauerDr Henrik MollerDr Göran MöllerMs Pearl MooreDr Marcos MoraesDr David MorganDr Gareth MorganDr Sally MorganDr David MorrisDr Randall MortonDr Henning MouridsenDr Nicola MozzilloMs Joyal MulheronDr James MulshineDr Alastair MunroDr Victoria MurdayDr Graeme MurrayDr J. MurrayDr Arnon NaglerDr E. NanbergDr Tsuguo NarukeDr S. NedospasovDr Eva NegriDr Thomas NevillDr Munro NevilleDr Rob NewboldDr H. NewellMr Laurence NewmanDr Vu Quoc NguyenDr Q. Nguyen ManhDr Ole NielsenDr Kenneth NilssonDr Olle Nilsson

Dr Aulikki NissinenDr Monica NisterDr Magnus NordenskjoldDr Amos NormanDr J. NortonDr O. NyrenDr Philippa O BrienDr P. O DwyerDr Franz OeschDr Karin OienDr G. OosterhofDr Willem OosterlinckDr Susanne OsantoDr Wolfram OstertagDr D. OwensDr B. OzanneDr Lars PahlmanMr Vakis PapanastassiouDr Valerio ParisiDr Chris ParkerDr Peter ParkerDr Rowan ParksDr Kristiina PatjaDr Jim PaulDr R. PayneDr Andrew PeacockDr Mick PeakeDr Lucy PeltenburgDr S. PercorelliDr Carlos PerezMs Sabine Perrier-BonnetDr Göran PershagenDr Harald Peter Dr Godefridus PetersDr Gordon PetersDr Olé PetersenDr Ruth PettengellDr Ulf PetterssonDr Herbert PfisterDr David PhillipsDr Luis Pinillos AshtonDr C. PinkertonDr Paola PisaniDr Christoph PlassDr K. PlattDr H. PloeghDr Miriam PoirierDr Bruce PonderDr Christopher PottenDr Jacques PouyssegurDr Barry PowellDr Judy PowellDr Pat PriceDr J. PrimroseDr E. PuréDr A. PurushothamMr Dennis PyritzDr David QuinnDr M. QuinnDr K. RajewskyDr Manfred RajewskyDr Zvi RamDr Muchlis RamliDr R. RamplingDr R. RamsayDr K. RaoDr Rao BhaskarDr U. RappDr Eric RaymondDr Zenon RayterDr Roger ReddelDr John ReedDr Nicolas ReedDr Robin ReidDr Sun RhaDr Peter Rhys-EvansDr Joseph RibakDr C. Rice-EvansDr A. RickinsonDr Thomas RiedDr Ulrik RingborgDr Olle RingdenDr Adolfo Rios SharpDr A. RobertsonDr Diane RobinsDr Tracy RobsonDr A. RocheDr M. RocheDr Piere RogallaDr Anna RohatinerDr Jens RohrbachDr Göran RoosDr Geoff RoseDr David RosenthalDr Carlo RossiDr A. RotDr Marianne RotsDr Varda RotterDr J. RoweDr Paul Rozen

Dr Marc RudoltzDr Curzio RüeggDr T. RuersDr Erkki RuoslahtiDr Kevin RyanDr Anders RydholmDr L. SachsDr Nigel SacksDr Azmat SadozyeDr Korinn SakerDr E. SakselaDr Yussuf SaloojeeDr André SappinoDr R. SaracciDr Mudan SatvinderDr M. SchartlDr Andreas SchätzleinDr P. ScheinDr Werner ScheithauerDr Rik ScheperDr Volker SchirrmacherDr Wolfgang SchlegelDr Anne Schmitt-VerhulstDr Bernadette SchoketDr P. SchrierDr V. SchumpelickDr Manfred SchwabDr Reinhard Schwartz-AlbiezDr Andrew ScottDr Crispian. ScullyDr Rolf SeljelidDr S. SenDr Suresh SenanDr Leonard SeymourDr Usmani Shahina ParveenDr Peter SharpDr Denise SheerDr P. SheldrickDr T ShenDr John ShepherdDr Shi-Xin LuDr Janet ShipleyDr Nadeem SiddiquiDr Jorg SiewertDr Paul SimmonsDr Bengt SimonssonDr A. SimpsonMr David SimpsonDr Freddy SitasDr S. SlavinDr Nicholas SlevinDr J. SmithDr Michael SmolaDr J. SmythDr Peter SnijdersDr Alexander SobolevDr Alberto SobreroDr Tomotaka SobueDr Mitchell SokoloffDr Jens SorensenDr Thierry SoussiDr David SoutarDr Demetrios SpandidosDr Valérie SpeirsDr Stephen SpiroDr Margaret SpitzDr Michael SpornMs Nathalie StahelinDr E. StanbridgeDr Patricia SteegDr Michael SteelDr R. SteinDr Bo StenerlowDr John StevensDr M. StevensDr Freda StevensonDr John StewardDr William StewardDr Simon StewartDr Hans StormDr Ronald StoutDr H. StranderDr Ian StratfordDr Gordon StrathdeeDr Robert StuartDr George StudzinskiDr Robert SudderickDr Christer SundstromDr Robert SutherlandDr Andrew SykesDr R. SymondsDr Kari SyrjanenDr Paul TalalayDr Paul TamDr Kimio TanakaDr Ping-Zhang TangDr Gunnar TanumDr Stephen TaylorDr Joel TepperDr Patrick Therasse

Dr Bruce ThomadsenDr Hilary ThomasDr José ThomasDr Valerie ThomasDr John ThompsonDr Magnus ThornDr Ian TomlinsonDr G. TozerDr D. TrichopoulosDr S TsuiDr I. TuressonDr V. UjhazyDr Mark UnderwoodDr Aysegul UnerDr Frederik Van DamDr Martin Van den BentDr A Van der EbDr Paul Van der SaagDr Ate van der ZeeDr Paul Van DiestDr Erik van LimbergenDr Allan Van OosteromDr Hendrik Van PoppelDr Jenny VarleyDr Paul VaseyDr Keith VassDr Tabare Vazquez RosasDr A. VeermanDr Aldo VenutiDr Marcel VerheijDr Sally VernonDr Luisa VillaDr Antonio VillalonDr Sarah VinnicombeDr Angela VironeDr Sabine von KleistDr Thomas von ZglinickiDr K. VousdenDr Stefaan VynckierDr Jürgen WahrendorfDr Korina WaibutaDr Michael WakelamDr Jan WallaceDr Jane WardleDr P. WardmanDr Paul WaringDr Roger WatsonDr D. WazerDr Steve WebbDr William WeiDr Wei-Cheng YouDr John WeinsteinDr John WeisburgerDr Mary WeissDr Robin WeissDr M. WeitznerDr C. WestDr Matthew WestDr B. WestermarkDr K. WestonDr Robert WhiteDr Stephen WigmoreDr Erik WilanderDr Christopher WildDr A. WileyMs Judy WilkenfeldDr Susie WilkinsonDr K. WilleckeDr E. WilliamsDr Gareth WilliamsDr A. WilliamsonDr Charles WilsonDr Myra WisotzkyDr H. WithersDr Penella WollDr John WongDr Siu-Fun WongDr C. WoodmanDr Richard WoosterDr Eric WrightDr Wei XiaoDr Hiroshi YamasakiDr Ke Yang Dr Tony YatesDr Cheng YipDr You-Hui ZhangDr Bryan YoungDr Lawrence YoungDr Ilana YronDr J. YuenDr Darwin ZachariasDr Michael ZalutskyDr Shu ZhengDr Zheng EhDr Jingde ZhuDr Olga ZhukovaDr Robert ZimmermanDr Franco Zunino


Volunteer Commitees

TNM Prognostic Factors Core Group

Dr Kenneth Nilsson Dr Leslie H. Sobin Dr Frederick L. Greene Dr Ellen Benhamou-BorowskiDr James BrierleyDr Louis J. DenisDr Carol Friedman Dr Mary GospodarowiczDr Patti A. GroomeDr Daniel Miller Dr Hextan Y.S. NganDr Brian O’SullivanDr Christian Wittekind Dr Susumu Yamasaki

TNM Process SubcommitteeDr Mary Gospodarowicz, ChairDr Carol FriedmanDr Frederick L. Greene Dr Patti A. GroomeDr Daniel MillerDr Hextan Y.S. Ngan Dr Leslie H. Sobin

TNM Pronostic FactorsSubcommitteeDr Mary Gospodarowicz, ChairDr Brian O’SullivanDr Leslie H. Sobin Dr Christian Wittekind

TNM Supplement EditorialSubcommitteeDr Christian Wittekind (Editor) Dr Leslie Sobin Dr Susumu Yamasaki (AssociateEditor)

TNM Atlas Editorial SubcommitteeDr Christian Wittekind (Editor) Dr Frederick L. Greene(Associate Editor) Dr Leslie Sobin Dr Susumu Yamasaki (AssociateEditor)

TNM Expert Panel

BreastDr Stephen B. Edge, USADr Patrick L. Fitzgibbons, USADr Daniel F. Hayes, USADr Eva Sonja Singletary, USADr Tim Whelan, USA

GastrointestinalDr Carolyn Compton, CanadaDr Bernard Cummings, CanadaDr Philip J. Johnson, ChinaDr Günter Klöppel, GermanyDr Christian Wittekind,GermanyDr Tadakazu Shimoda, JapanDr Norman Carr, UKDr John Primrose, UKDr Jorge Albores-Saavedra, USADr Cecilia Fenoglio-Preiser,USADr J. Milburn Jessup, USADr Thian Lok Tio, USADr Stuart J. Spechler, USADr Sidney J. Winawer, USA

GenitourinaryDr Louis Jean Denis, BelgiumDr Hideyuki Akaza, JapanDr Adrian van der Meijden,NetherlandsDr Fernando Algaba, SpainDr Dean Bajorin, USADr James Montie, USADr Alan Pollack, USADr Mack Roach III, USADr Ian Thompson, USA

GynaecologicDr J.Lou Benedet, CanadaDr Anthony Fyles, CanadaDr Hextan Y.S. Ngan, ChinaDr Sergio Pecorelli, ItalyDr William T. Creasman, USADr William J. Hoskins, USADr Howard Jones III, USADr Maurie Markman, USA

Head & NeckDr Brian O’Sullivan, CanadaDr Anne W.M. Lee, ChinaDr Vincent F.H. Chong,SingaporeDr Jesus Medina, USADr Suresh Mukherji, USA

LungDr David Ball, AustraliaDr Michael Brundage, CanadaDr Frances Shepherd, CanadaDr Thierry Le Chevalier, FranceDr Roysuke Tshuchiya, JapanDr Peter Goldstraw, UKDr Ned Patz, USADr Valerie W. Rusch, USADr William D. Travis, USA

LymphomaDr Andrew Wirth, AustraliaDr Lena Specht, DenmarkDr Emanuele Zucca, SwitzerlandDr Alan Horwich, UKDr Richard Hoppe, USADr Peter Mauch, USA

Sarcoma/BoneDr Peter Choong, AustraliaDr Robert S. Bell, CanadaDr Brian O’Sullivan, CanadaDr Ian Judson, UKDr Peter W. T. Pisters, USADr Raphael E. Pollock, USADr Sharon Weiss, USA

SkinDr Peter Heenan, AustraliaDr Michael G. Poulsen, AustraliaDr John Thompson, AustraliaDr Richard Tsang, CanadaDr Natale Cascinelli, ItalyDr David Elder, USADr Martin C. Mihm, USADr George Murphy, USA

TNM National Committees

BelgiumDr Louis Jean Denis (Chair)

CanadaDr James Brierley (Chair) Dr Audley Bodurtha Dr Carolyn Compton Dr Pierre Drouin Dr Dagny Dryer Ms Maureen MacIntyre Dr John Srigley

FranceDr Ellen Benhamou-Borowski(Chair)

Germany/AustriaDr Christian Wittekind (Chair) Dr Martin Klimpfinger Dr Elfriede Bollschweiler Dr F. Bootz Dr H. Breuninger Dr H. Dralle Dr P. Drings Dr E. Dühmke Dr P. Eysel Dr C. Garbe Dr Norbert Graf Dr F. Hasse Dr P. Hermanek Dr H-P. Howaldt Dr G. Jakse Dr Th. Junginger Dr Kiwit Dr Friedrich Kommoss Dr Ulrich Mansmann Dr H.-J. Meyer Dr H.-D. Saeger Dr Dietrich von Schweinitz Dr G.A. Wagner Dr Anette Weber Dr P. Wirth

ItalyDr Fausto Badellino (Chair) Dr Gianni Anaveri Dr Pierluigi Benedetti Panici Dr Marcello Canale Dr Manuel A. Castello Dr Francesco Cianfriglia Dr Anna Di Iorio Dr Mauro Dimitri Dr Andrea Forestieri Dr Massimo Gasparini Dr Roberto Giardini Dr Domenico Messina Dr Lucio Miano Dr Guido Mosella Dr Giuseppe Paladini Dr Marco Piemonte Dr Paolo Pronzato Dr Marco Rosa Dr Nicolo Scuderi Dr Vincenzo Stipa Dr Fabio Volterrani

JapanDr Susumu Yamasaki (Chair) Dr Yasuo Beppu Dr Shin-ichi Egawa Dr Tomi Hayashi Dr Iwao Ikai Dr Akihiro Kaneko Dr Takahiro Kasamatsu Dr Hitoshi Katai Dr Takayuki Kinoshita Dr Kenjirou Kotake Dr Takuwa Nagakawa Dr Yoshitaka Okamoto Dr Masahisa Saikawa Dr Souichirou Shibui Dr Yuuji Tachimori Dr Takashi Watanabe Dr Akifumi Yamamoto

RussiaDr Nikolay N. Blinov (Chair)

United Kingdom Dr Michael W. E. Morgan(Chair)

United States of AmericaDr Frederick L. Greene (Chair)

Capacity Building

Strategic Leader: Dr RobertBurton (all sub groups)

Capacity Building Oversight GroupDr Louis DenisDr Kate DinshawDr Jeff DunnProf. Hélène Sancho-GarnierDr Yip Cheng Har Mr Michael F. HeronMr Tom Hudson Dr Melissa LuwiaDr Yussuf Saloojee

National Cancer ControlStrategic Planning Task ForceDr Mark ElwoodDr Arun Kurkure Dr Eliezer RobinsonJanine Nesset TominagaDr Thierry PhilipDr Sherif Omar

Network Development Task ForceMs Catherine DickensMr Tom Hudson Ms Ranjit KaurDr Roy West

Capacity Building Materials Task ForceDr Jeff DunnMr Tom Hudson Dr Melissa LuwiaMs Johanna RalstonMs Dorothy Reading

Patient Support Task ForceDr Jeff Dunn

Reach to Recovery CommitteeAnn SteynMiri ZivMaria Ines Marchegiani de UckeIrina KozulinaKaren VeienMaria MatosAlka Kapadia

Reach to Recovery NewsletterEditorial BoardRanjit KaurLohes RajeswaranJeff DunnTom HudsonAnn SteynEvelyn Zuberbühler

Communications

UICC Communications WorkingGroupDr Mary Gospadarowicz Dr Ray Lenhard Mr Fred MickelsonDr Roy WestDr Elmer E. Heurta

Conferences

UICC Advisory Group onInternational ConferencesDr Jeff Dunn (Chair)Dr Liisa ElovainioProf. Helene Sancho-GarnierMr Michael F. HeronProf. David Hill (Chair)Ms Pearl Moore

Membership

UICC Membership andGovernance Task ForceMr John Baity Dr Alan CoatesDr Louis DenisDr Kate DinshawDr Mary Gospodarowicz, ChairDr Tomoyuki KitagawaMr Bruno MeiliDr Eliezer RobinsonDr John Seffrin (ex-officio member)

International Journal of Cancer

International Journal of CancerEditorial BoardEditor in ChiefProfessor H. zur Hausen

Associate EditorsHelmut BartschNorbert FusenigMagnus von Knebel DoeberitzPeter H. KrammerPeter LichterAnthony Miller

Managing EditorSherryl Sundell

Editorial BoardLauri A. AaltonenStuart A. Arsonson Kari AlitaloBruce Armstrong Mariano Barbacid J.Carl Barrett Walter Birchmeier Mina J. Bissell Mikhail V. Blagoskonny Thomas Boehm Thierry Boon MaxM. Burger Walter Cavenee Pelayo Correa Jack Cuzick Albert de la Chapelle Wafik El-Deiry

Adi F. Gazdar William E. Grizzle Ulf Gyllensten Curtis C. Harris Carl-Henrik Heldin James G. Herman Monica Hollstein Waun K. Hong Peter M. Howley Tadao Kadizoe T. Kishimoto Paul Kleihues Alexander Knuth Stanley J. Korsmeyer Carlo La Vecchia David Lane Gilbert M. LenoirArnold J. Levine Frederick P. Li Lawrence A. Loeb David Malkin C.J.L.M. MeijerKees Melief Ira Mellman Paul Meltzer Patrick S. Moore Steven A. Narod Brian J. Nickoloff M. Oren Donald Maxwell Parkin Roger Reddel Guido ReifenbergerJanet D. Rowley Erkki Ruoslahti Keerti V. Shah Kunitada Shimotohno Michael R. Stratton Tadatsugo Taniguchi Masaaki Terada Ian Tomlinson P. Vineis S.H. Yuspa

eUICC

eUICC Think TankMary GospodarowiczIsabel MortaraRuben IsraelAlex JadadAndrea A. CortinoisDoina LupeaEnrico CoieraMary Ann LansangRafa BravoDavid H. GustafsonLisa BeroJeremy WyattJoan DzenowagisRaymond LenhardNancy LorenziVic NeufeldSylvia RoblesSilvana LucianiDaniel S. MillerWilliam MackillopArun Kurkure


Country Project Name

Jamaica ICR Dr Garfield BlakeKazakstan TCS Dr Alma ZhylkaidarovaKenya ICR Dr Geoffrey Mutuma

ION Mr John NderiION Mr Justus Osano

Korea (South) FCT Ms Jin-Sook ChoiTCS Dr Sun Jee

Latvia ICR Dr Olga SinickaMalawi FCT Mr John KapitoMalaysia TCS Dr Mohamad Nik MohamedMexico TCS Mr Raydel Valdes-SalgadoNepal FCT Mr Shanta Mulmi

ICR Dr Ashok JoshiICR Dr Nirmal LamichhaneICR Dr Manohar Pradhan

Nepal ICR Dr Raj RauniyarION Ms Ganga HumagaiION Ms Usha Thapa

Nigeria FCT Mr Matthew OluwafemiPakistan FCT Dr Ehsan Latif

ION Ms Hadj HadjirulPoland ICR Dr Grzegorz Basak

ICR Dr Aneta BialkowskaICR Dr Przemyslaw JuszczynskiICR Dr Andrzej KomorowskiICR Dr Wojciech SobalaYY1 Dr Maria Ciemerych-LitwinienkoYY2 Dr Jacek Gronwald

Romania TCS Dr Magadalena CiobanuRussia ICR Dr Karina Budagova

ICR Dr Olga GurianovaICR Dr Elena IoudinkovaICR Dr Julia MalovaICR Dr Oxana ShanginaTCS Dr Olga Vikhireva

Saudi Arabia ICR Dr Malak BokhariICR Dr Khaled Zaza

Serbia and Montenegro ICR. Dr Milutin BaucalSingapore YY1 Dr Prakash HandeSlovak Republic ICR Dr Juraj Baumohl

ICR Dr Jan GurskySlovenia ICR Dr Jozko Cesar

ICR Dr Ibrahim EdhemovicSlovenia ICR Dr Irena FondaSouth Africa ICR Dr Babatyi Malope

ION Ms Nontuthuzelo SomdyalaSpain ICR Dr Turid Hellevik

ICR Dr Guillem Pera BlancoSri Lanka ICR Dr S. PereraSwitzerland TCR Dr Markus JörgerTanzania TCS Dr Robert MachanguThailand ICR Dr Patravoot VatanasaptTunisia ICR Dr Naira Ben Mami

ION Ms Rabiaa AntriUganda FCT Mr Phillip Karugaba

TCS Mr Phillip KarugabaUK ACS Dr Alexander Thompson

ICR Dr Michael MilsomTCR Dr Erik Sahai

Ukraine YY2 Dr Marta LomnytskaUruguay FCT Mr Eduardo Bianco FonsaliaUSA ICR Dr Valentine Andela

ICR Dr Awtar GanjuICR Dr Ray MerrillYY1 Dr Howard Young

Vietnam TCS Ms Thu Le ThiZambia FCT Mr Muyunda Ililonga

TCS Mr Muyunda Ililonga

Fellows 2003Country Project Name

Argentina FCT Ms Mirta MolinariICR Dr Mariana BonduelICR Dr Paula Fernandez-CalottiICR Dr Dora LoriaICR Ms Natalia Rumie VittarTCS Dr Raul PitarqueYY2 Dr Daniel Hochbaum

Armenia ICR Dr Ruben HovhannisyanAustralia ICR Dr Natalia Gousseva

ICR Dr Laura PappYY1 Dr Terrence MulhernYY2 Dr Nuzhat AhmedYY2 Dr George Yeoh

Bangladesh FCT Mr Saifuddin AhmedBelarus ICR Dr Alexander MeleshkoBrazil ICR Dr Renata Sandoval

TCR Dr Luiz De MarcoTCS Dr Paulo Correa

Bulgaria ICR Dr Victoria Sarafian OzanyanBurma Myanmar TCS Dr Nyo KyaingChina ACS Dr Yizhuang Xu

ICR Dr Bing-Jian FengChina ICR Dr Bin Lu

ICR Dr Yanzheng SongICR Dr Zhongshu Yan ICR Dr Meiqin ZhangICR Dr Zongli ZhengTCS Dr Yuan JiangYY1 Dr Quan Chen

Colombia ICR Dr Luis BravoCroatia TCS Dr Verica KraljCuba ICR Dr Julia Cruz Mojarrieta

ICR Dr Giselle Saurez MartinezCzech Republic FCT Dr Katerina Langrova

ICR Dr Marketa NowakovaEgypt ICR Dr Tarek ShoumanFrance ACS Dr Florence Joly

ICR Dr Sophie KusyYY1 Dr Claude Prigent

Georgia FCT Dr George BakhturidzeGermany ACS Dr Corinna Bergelt

ACS Dr Corinna BergeltGhana ICR Dr Ernest Chinbuah

ION Ms Jessie AdanusahGreece ICR Dr Lina VardouliHungary ACS Dr Arpad Farkas

ACS Dr Arpad FarkasICR Dr Tamas BeötheICR Dr Katalin Nagy

India ACS Dr Rajesh DikshitACS Dr Rajesh DikshitAPC Mr Samiran DasAPC Dr Sanghamitra PatiAPC Ms Anita PeterFCT Ms Shoba JohnICR Dr Pratibha Amare KadamICR Dr Monish AronICR Dr Neerja BhatlaICR Dr S. DeoICR Dr Aloke Ghosh DastidarICR Dr Manoj GuptaICR Dr Elizabeth Mathew IypeICR Dr Upen MathurICR Dr Ghanshyam MundhadaICR Dr Rekha NairICR Dr Murthy Pisapati ICR Mr Victor PrabakarICR Dr Subrata SahaICR Dr B. SharmaICR Dr Mehar SharmaICR Dr Raj SharmaICR Dr Subramani SridharanTCS Ms Monika AroraYY1 Dr Jagmohan SinghYY2 Dr Partha Basu

Iran ICR Mr Ramin JaberiICR Dr Reza KhodabakhshiICR Dr Masoud MireskandariICR Dr Seyed Yahya Zadeh Jabbari

Ireland ICR Dr David EastyIsrael ACS Dr Michael Brandeis

ACS Dr Michael BrandeisICR Dr Benjamin KleinICR Dr Ilana Yron

Italy ICR Dr Barbara BottazziICR Dr Laura DapraiICR Dr Susanna MandruzzatoICR Dr Augusto OrlandiICR Dr Patrizia PerriICR Dr Giulia PiaggioICR Dr Alessandra RinaldoYY2 Dr Giovanni Vitale


Total expenditure in 2003 US$ 4,616,697

Combined restricted and unrestricted income 2003US$ 5,797,871

Fellowships and project activitiesMembership duesPublicationsOther

Fellowships and project activitiesInformation and publicationsManagement and programme support

564,212 1,455,071 687,226

2,781,076 997,512 3,084,726 844,745

Balance Sheet as at 31st December 2003 in US Dollars

Assets

Liabilities and Fund Balance

Unrestricted:

Donor Restricted:

Unrestricted:

Donor Restricted:

Cash:Current accuntsTime depositsAccounts receivable:Membership duesRelated partiesOtherPrepaid expensesFixed assetsTOTAL

Receivable from unrestricted funds

Accounts payable and accrued expenses:Related partiesOtherDue to restricted fundsReserve for blocked currenciesOther liabilitiesTranslation differenceStatutory reserveFund balanceTOTAL

Trust funds

2003

230,5233,397,033

60,9083,412

54,02919,79733,180

3,798,882

1,833,742

40,473173,149

1,833,74211,540

634,21292,484

100,000913,282

3,798,882

1,833,742

2002

1,148,9281,024,596

5,4028,386

183,4495,419

86,6672,462,847

1,462,501

41,698297,246

1,462,50110,025

493,75954,270

-103,348

2,462,847

1,462,501

UICC Staff 2003

Executive DirectorIsabel Mortara

Assistant to the Executive DirectorEvelyn Zuberbuhler

Prevention & Early DetectionMaria Stella de Sabata

Tobacco Control – GLOBALinkRuben IsraelMargaret WalkerHarold ColomesJacqueline DropeFatma HassanTatiana AndreevaStan Shatenstein

Knowledge TransferBrita BakerKaren Silverman Raluca Grigorescu

Capacity BuildingLohes Rajeswaran

Finance & AdministrationRobert DuboisItalo Goyzueta Annie Imhof Delphine Langer Jeannette Nyandwi Philomène Taylor Anouk Vittori

CommunicationsJanice BlondeauCarlos OcamposJérôme PitaultJJ Divino

eUICCLaura Heller

Relay for LifeAna Olivera

ACS LiaisonNancy LinsRoger Sullivan


UICC has made every effort to ensure all information contained in this Annual Review is accurate, and cannot be held responsible for any inadvertent errors that may have occurred.

UICC is the only international non-governmental organisation dedicated exclusively to the global control of cancer.Its vision is of a world where cancer is eliminated as a major life-threatening disease for future generations.

resource for actionvoice for change

International Union Against Cancer (UICC)3, rue du Conseil Général • 1205 Geneva • SwitzerlandTél.: +41 22 809 18 11 • Fax: +41 22 809 18 10 • email: [email protected] • Website: wwww.uicc.org

uicc annual report 2003

Documents